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Abstract 
Student/author: Ingebjørg Aspeland Lien. 
Title: Personality problems among patients with substance use disorders: Assessment and 
clinical implications. 
Supervisor: Espen Ajo Arnevik.  
Background and aim: Several studies have shown that personality disorders (PDs) are 
frequently occurring among patients with substance use disorders (SUDs). A development 
from the research of co-occurrence estimates in this patient group is investigating personality 
problems. Personality problems are dimensional constructs aiming to capture the core of 
personality pathology. The aim of the study was to investigate personality problem severity 
among Norwegian adult SUD patients. Personality problems were assessed using the self-
report questionnaire Severity Indices of Personality Problems (SIPP-118). Furthermore, we 
sought to explore the association between substance use characteristics (poly-substance use, 
injection use, age of debut and primary preferred substance) and personality problem severity.  
Method: The study used a cross-sectional design based on questionnaires, which included the 
SIPP-118 as well as questions on demographic data and substance use characteristics. The 
study sample consisted of 155 SUD patients currently in treatment at detoxification sections 
at Oslo University Hospital. Data was gathered by the student in a period of seven months, 
from July 2014 to January 2015.  
Results: The results indicated that SUD patients have personality problems at a level of 
severity comparable to previously investigated PD patient samples, and significantly more 
severe than personality problems found in normal population samples. This indicates that 
personality problems is a common, as well as detrimental, feature among SUD patients, which 
further points towards considering these in all aspects of SUD treatment. None of the 
investigated substance use characteristics were significant predictors of personality problem 
severity. Thus, the study points to a need for separately assessing personality pathology in 
SUD patients. Though psychometric evaluation of the SIPP-118, we found that personality 
problems could be assessed reliably and validly in SUD patients during detoxification. This is 
an important contribution to the discussion concerning time and context of personality 
pathology assessment in the SUD treatment field, which might also have clinical implications.  
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Clinical implications: Assessing personality problems early in treatment might make possible 
a more integrated approach to SUD treatment, where personality problems, as well as 
substance related problems, are targeted. The study also indicates a need for greater 
integration of knowledge and methods from PD treatment into the SUD treatment field.  
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1 Introduction 
1.1 Substance use disorders 
Use of drugs places high costs on society, including decreased productivity, health problems, 
costs relating to substance-related crime and impact on public safety (International Narcotics 
Control Board, 2013). In addition to financial burdens, families, children, friends and 
environment are affected by substance use disorders (SUDs). SUD is an immense personal 
burden for affected individuals, impacting mental and physical health, ability to work, 
participation in society, as well as interpersonal relationships. The World Health Organization 
(WHO) estimates that substance use accounts for 10 percent of all life years lost (premature 
mortality) globally (United Nations Office on Drugs and Crime, 2012). SUDs are among the 
most prevalent mental disorders in Norway. According to the annual report on health in the 
Norwegian population, lifetime prevalence of SUDs is between 10 and 20 percent 
(Folkehelseinstituttet, 2014). Harmful use of or dependence on alcohol (International 
Classification of Diseases 10 (ICD-10) code F10) is the most frequently occurring SUD in 
Norway, while poly-substance use (ICD-10 code F19) is the second most frequent. 
Dependence is a complex and multifaceted field of study, and many theories have been 
developed to explain the origin and maintenance of SUDs (West & Brown, 2013). Among 
these, the bio-behavioral diathesis-stress model is frequently used to conceptualize the 
etiology of SUDs (Verheul & van den Brink, 2000). This means that the onset and course of 
SUD is considered a result of the continuous and mutual interaction between an individual’s 
biological and psychological vulnerabilities and resources on the one hand, and psychosocial 
environment on the other hand. Multiple vulnerability factors in the individual and the 
psychosocial environment increases the chance of developing the disorder. 
Substance use disorder (SUD) is defined as: “A cluster of physiological, behavioral, and 
cognitive phenomena in which the use of a substance or a class of substances takes on a much 
higher priority for a given individual than other behaviors that once had greater value” 
(WHO, 1992). According to the ICD-10 definition of SUD, harmful substance use (abuse in 
the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)) and dependence are 
collectively referred to as substance use disorders (Miele et al., 2000). The terms “addiction” 
and “dependence” have been widely and variably used, and might be hard to define and 
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operationalize (Kranzler & Li, 2008). Therefore, for the purpose of this thesis, substance use 
disorder (SUD) according to the ICD-10 will be the preferred term. 
1.2 Personality and personality problems 
In his 1937 book “Personality: a Psychological Interpretation”, Gordon Allport states that 
personality “… is what lies behind specific acts and within the individual. The system that 
constitute personality is in every sense determining tendencies and when aroused by suitable 
stimuli provide those adjustic and expressive acts by which personality comes to be known” 
(Allport, 1937, p. 48). The essence in this definition is that personality is a person’s general 
tendency to react, behave, think and feel across situations. A central element when discussing 
personality is traits. Personality traits can be defined as “… the relatively enduring patterns of 
thoughts, feelings and behaviors that reflect the tendency to respond in certain ways under 
certain circumstances” (Roberts, 2009, p. 140). A known and agreed upon model of the 
structure of normal personality, classified by personality traits, is Costa and McCrae’s five-
factor model (Saulsman & Page, 2004). The five traits represented in this model are 
neuroticism, extraversion, agreeableness, conscientiousness and openness to experience.  
Personality consists of traits and structures that characterize personality as well as the 
functions that these traits and structures perform and the adaptive purposes they serve 
(Livesley & Jang, 2000). As stated by Allport (1937, p. 48): “Personality is something, and 
personality does something”. What personality does, the functional domain of personality, can 
be labelled adaptive capacities (Bastiaansen, De Fruyt, Rossi, Schotte, & Hofmans, 2013). 
The adaptive capacities usually refer to the organization of personality that includes 
regulation of self; value of the self, identity and control over impulses, and interpersonal 
functioning; mentalization capacity, creating and maintaining meaningful intimate 
relationships and empathy (Livesley & Jang, 2000). Development of adaptive capacities starts 
early in life, are learned in social contexts, and the capacities’ development continue 
throughout the life course (Andrea et al., 2007).  
Life tasks, such as identity formation and establishing meaningful interpersonal relationships, 
are adaptive problems a person must fulfil to develop functionally. While solutions to these 
tasks form core components of personality, failure to solve them can lead to malfunctioning 
of the adaptive capacities. When the adaptive capacities function maladaptively, they can be 
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referred to as personality problems (Andrea et al., 2007). Furthermore, dysfunctioning of the 
adaptive capacities; the personality problems, are believed to form the core components of 
personality disorders (PDs) (Livesley & Jang, 2005). In the alternative criteria for PDs in the 
Diagnostic and Statistical Manual of Mental Disorders, 5
th
 ed. (DSM-5), it is proposed that 
PDs are characterized by significant impairments in self- (identity and self-direction) and 
interpersonal (empathy and intimacy) functioning (American Psychiatric Association, 2013). 
This is in accordance with a perspective that normal and pathological personality is 
distributed dimensionally, held by many researchers (Arnevik, Wilberg, Monsen, Andrea, & 
Karterud, 2009). The adaptive capacities are also believed to be dimensional phenomena, 
meaning that more severe personality pathology is related to less adaptive capacities, and thus 
more severe personality problems. Adaptive capacities are in continuous development, and 
are available to change (Bastiaansen et al., 2013). This can help to explain why diagnostic 
stability for PDs seems to be lower than previously assumed, and explain change due to 
therapeutic interventions (Arnevik et al., 2009). The clinical relevance of the concept of 
personality problems makes them an interesting topic of study. 
1.3 Relationship between SUDs and personality 
problems  
In researching the link between dependence and personality, several studies have explored 
comorbidity rates between SUDs and PDs. In these studies, one finds that a large portion of 
SUD patients meet criteria for an axis II-diagnosis, and similarly that a large portion of 
patients with a diagnosis of PD also have a SUD diagnosis (Karterud, Wilberg, & Urnes, 
2010; Skodol, Oldham, & Gallaher, 1999; Verheul & van den Brink, 2005). The prevalence 
rates vary between different types of substances as well as for the different PDs and PD 
clusters (Arefjord, 2011). Rates of co-occurring SUD-PD are found to be lower among 
patients primarily using alcohol (ICD-10 code F10) than among those using other or multiple 
substances (ICD-10 code F11-19). Grant et al. (2004) found that 29% of individuals with 
SUD using alcohol had at least one co-occurring PD, while the rate was 48% among 
individuals with SUD using other or multiple substances. Antisocial personality disorder 
(ASPD) and borderline personality disorder (BPD) are the most frequently occurring PDs 
among individuals with SUDs (Grana, Munoz, & Navas, 2009; Grant et al., 2004; Karterud et 
al., 2010; Landheim, Bakken, & Vaglum, 2003). In their literature review Trull, Sher, Minks-
 4 
 
Brown, Durbin, and Burr (2000) found that 57% of individuals diagnosed with BPD met 
diagnostic criteria for SUD. Impulsivity and externalization, typical characteristics of ASPD 
and BPD, seem to be important factors for explaining the association between SUDs and PDs 
(Jahng et al., 2011; Sher & Trull, 2002). 
There has been research into whether SUDs can contribute to, or cause personality problems, 
or vice versa. Reviewing literature on the relationship between SUD and BPD, Trull et al. 
(2000) argue that SUD can contribute to aspects of personality problems. The substances’ 
neurological and neurotoxic effects are important to consider in this regard. Examples are 
serotonin depletion resulting from high intake of alcohol leading to impulsivity (Carver & 
Miller, 2006), or the substances’ effect on neurodevelopment leading to difficulties with 
executive functions important for self-regulation and problem-solving among other things 
(Trenz et al., 2012). Another explanation for the association is the possibility that individuals 
with personality problems might turn to substances to self-medicate affective or interpersonal 
disturbances, thus influencing the development of SUDs (Flores, 2001). Yet another 
possibility is that SUDs and PDs are both caused by a common factor, such as childhood 
traumas or genetic factors (Sher & Trull, 2002). A fourth option is that co-occurring SUDs 
and personality problems maintain each other. There has been some evidence that SUDs 
increase the chronicity of BPD, and that BPD increases the chronicity of SUDs (Trull et al., 
2000). To date, there is no evidence solidly supporting one influence over the other. The term 
co-occurring disorders imply two disorders with a purely temporal relationship, and not 
necessarily a common underlying cause or related etiologies (Morisano, Babor, & Robaina, 
2014). Because the questions concerning related etiologies or common causes are too 
complex for the scope of this thesis, the term co-occurrence will be preferred over 
comorbidity. 
1.3.1 The association between substance use characteristics and 
severity of personality problems 
It has been proposed that substance use problems, like personality problems, can be viewed as 
being distributed dimensionally rather than as categorical states (Gossop, Griffiths, Powis, & 
Strang, 1992; Kranzler & Li, 2008). This allows us to talk about severity of substance use. On 
the basis of literature reviewed (Colpaert, De Maeyer, Broekaert, & Vanderplasschen, 2013; 
Gonzales et al., 2011; Gossop et al., 1992; Latimer, Newcomb, Winters, & Stinchfield, 2000), 
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the following four characteristics are considered indicators of substance use severity: poly-
substance use, route of administration, age of debut and primary preferred substance. These 
relate to different aspects of substance use, and might be associated differently with each 
other and with other indicators of mental health. 
Poly-substance use, injecting use and early age of debut are factors associated with increased 
risk of developing a SUD and longer duration substance use (Domier, Simon, Rawson, Huber, 
& Ling, 2000; Magid & Moreland, 2014; Trenz et al., 2012). These indicators of substance 
use severity are also associated with negative long-term consequences for mental and physical 
health (Di Poggio et al., 2006; Domier et al., 2000; Gruber, DiClemente, Anderson, & Lodico, 
1996; Taplin, Saddichha, Li, & Krausz, 2014). Higher rates of co-occurring personality 
pathology are found among SUD patients with poly-substance use and/or injecting use 
compared to SUD patients only consuming one substance per day and employing other routes 
of administration (Landheim et al., 2003; Saint-Lebes, Rodgers, Birmes, & Schmitt, 2012; 
Verheul, van den Brink, & Hartgers, 1995). Early onset of substance use might be an 
indicator of more severe pathology, and is of concern among other things due to how the 
substances’ neurotoxic effects might interfere with neurodevelopment and development of 
executive functions (Trenz et al., 2012). 
There is an ongoing discussion concerning the relevance of primary preferred substances of 
use. Several studies have found common characteristics among subgroups of substance users 
based on their primary preferred substance, such as heroin (Di Poggio et al., 2006; Hopfer, 
Mikulich, & Crowley, 2000) and stimulants (Wu, Pilowsky, Wechsberg, & Schlenger, 2004). 
Other studies have found primary substance of use to be a less important indicator of overall 
severity compared to factors such as co-occurring mental disorders, poly-substance use and 
economic adjustment (Campbell et al., 2013). An agreed upon division, both theoretically and 
clinically, is the one between substance users preferring alcohol and those preferring other 
substances (these are often poly-substance users). Co-occurring SUD-PD with alcohol as 
preferred substance seem to be less harmful than with other or multiple substances (Landheim 
et al., 2003; van den Bosch & Verheul, 2007). 
1.3.2 Clinical implications 
The reviewed literature finds that presence of PD diagnoses among SUD patients admitted for 
treatment is frequently occurring. Co-occurrence of SUD-PD is associated with greater 
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functional impairment (Skodol et al., 1999) and a mutual deterioration of the prognosis 
(Karterud et al., 2010; Trull et al., 2000), indicating a need for increased focus on developing 
effective treatment for this group of patients. Typical treatment considered for low 
functioning SUD patients is inpatient treatment focusing on substance use related problems 
(Gossop, 2001). This treatment might not be suited to meet the whole range of problems SUD 
patients encounter. Research indicates that personality pathology is common among SUD 
patients, which means that knowledge the PD treatment field might be valuable contributions 
to SUD treatment. One aspect concerns what treatment setting these patients are admitted to. 
While there has been political focus over the last years on increasing the number of inpatient 
places within SUD treatment (Hatlebakk, 2014), outpatient treatment is the recommended 
format for patients with BPD and ASPD (National Institute for Health and Clinical 
Excellence, 2009a, 2009b). If PD treatment guidelines were translated to the field of SUD 
treatment on the basis of high co-occurrence rates between SUD-BPD and SUD-ASPD, this 
would possibly call for restricted inpatient treatment of SUD patients. Another aspect 
concerns the possibility for more integrated treatment approaches. Integrated treatment targets 
the co-occurring disorders simultaneously, which means introducing approaches and methods 
from the PD treatment field into SUD treatment for the purpose of targeting personality 
pathology. 
To gain further insight into SUD patients’ functioning and to determine what treatment type 
and setting is adequate for these patients, it might be important to assess personality problems. 
A traditional assumption among clinicians working with SUD patients has been that one must 
wait until a period of abstinence before measuring personality pathology (Marlowe, Husband, 
Bonieskie, Kirby, & Platt, 1997). However, at this stage, treatment format and approach 
might have been chosen and treatment might have started and progressed. This presents a 
problem if aspects other than substance use related problems should be deciding factors for 
treatment. Thus, assessing personality problems at an early stage in treatment may have 
clinical implications. An important question is therefore how and when we can assess 
personality problems in SUD patients. 
1.4 Assessment of personality problems 
Different instruments have been developed to assess an individual’s personality pathology, all 
with their understanding of personality pathology as well as specific limitations and benefits. 
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One of these instruments is the Structured Clinical Interview for DSM-IV Personality 
Disorders (SCID-II). The SCID-II is a clinical interview assessing diagnostic criteria for the 
10 PDs in the DSM classification system, used to assess diagnoses of PD. One assumption 
behind this diagnostic instrument is that normal and abnormal personality belong to 
qualitatively different domains, which is now objected by many researchers (van Kampen, 
2002). The Revised NEO Personality Inventory (NEO PI-R) is another instrument used for 
assessing personality pathology. This questionnaire measures the five major domains of 
personality presented in Costa and McCrae’s five factor model (Ryder, Costa, & Bagby, 
2007). An assumption behind the clinical use of this instrument is that personality pathology 
represents extreme and maladaptive variants of normal personality traits (Lynam, 2012). 
Another instrument is the Dimensional Assessment of Personality Pathology – Basic 
Questionnaire (DAPP-BQ). This instrument is based on a dimensional model of PDs, 
assessing the major common dimensions across personality pathology (van Kampen, 2002). 
The Severity Indices of Personality Problems (SIPP-118) is an instrument assessing the core 
components across PDs, referred to as personality problems. The questionnaire was 
developed by Dutch and British clinical experts in the field of personality and PDs for 
research purposes as well as for clinical purposes. The SIPP-118 aims to measure an 
individual’s levels of adaptive capacities at a given time, and can indicate in which areas of 
personality functioning treatment is needed and which areas are adaptive and resourceful 
(Verheul et al., 2008). Furthermore, the SIPP-118 can be used as a measure of change due to 
treatment, indicating which capacities have improved and become more adaptive (Verheul et 
al., 2008). The SIPP-118 has currently been tested with five samples. In the initial validity 
study of the SIPP-118, personality problems were assessed in a Dutch PD sample (N=555) 
and a Dutch normal population sample (N=478) (Andrea et al., 2007). Personality problems in 
a Norwegian PD sample (N=114) were assessed in the Ullevål Personality Project (Arnevik et 
al., 2009). The SIPP-118 has also been tested with a clinical and a non-clinical adolescent 
sample (Feenstra, Hutsebaut, Verheul, & Busschbach, 2011). Overall, the SIPP-118 shows 
promising psychometric properties, is widely used for assessing personality problems at 
specialized treatment facilities for patients with PDs throughout Norway and addresses the 
adaptive capacities not formally limited to abstinence. Thus, the SIPP-118 was chosen to be 
the assessment instrument used in this study. 
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The need for specific assessment of personality functioning in patients in the mental health 
care is generally acknowledged (American Psychiatric Association, 2006; Langås, Malt, & 
Opjordsmoen, 2012; Verheul, 2001). Focus on the clinical importance of assessing 
personality pathology within the SUD field has increased with research focusing on patients 
with co-occurring SUD and mental disorders, among these PDs, and their treatment needs. An 
interesting topic of study is therefore whether instruments used for assessing personality 
functioning in other clinical populations, also validly and reliably can be used to assess 
personality functioning in SUD patients. 
1.5 Problem presented and hypotheses 
A development from the research of co-occurrence estimates is to investigate the levels of 
personality problems in Norwegian SUD patients. Study of the dimensional construct 
personality problems compared to the type-based PD diagnoses in relation to SUD, is a 
relatively new and undiscovered field of study. 
Drawing from previous research on substance use characteristics, the study will explore the 
relationship between substance use severity and severity of personality problems. If apparent 
differences in personality problems by substance use characteristics are found, this could 
indicate different treatment needs for different subgroups of SUD patients. 
1.5.1 Hypotheses  
1.  On the basis of reviewed literature showing that more than 50% of SUD patients meet 
diagnostic criteria for one or more PDs, we expect to find that SUD patients have severe 
personality problems. Personality problems are previously assessed in three adult samples; a 
Dutch PD sample and a Dutch normal population sample, and in a Norwegian PD sample 
(Andrea et al., 2007; Arnevik et al., 2009). Comparing our study sample with these three 
samples, we expect to find that Norwegian SUD patients have personality problems at a level 
of severity comparable to the PD population, and significantly different from the normal 
population, as measured by the SIPP-118. 
2. It is expected that severity of substance use; poly-substance use, injecting route of 
administration, early age of substance use debut and primary preferred substance not being 
alcohol, is related to severity of personality problems. 
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a. The negative consequences of poly-substance use, such as impact on mental and 
physical health (Di Poggio et al., 2006), as well as quality of life (Colpaert et al., 2013) are 
widely acknowledged. SUD patients with poly-substance use are found to have higher rates of 
co-occurring PDs than non-poly-substance users (Landheim et al., 2003; Verheul et al., 1995). 
Reflecting these research findings, we expect to find that the negative impacts of poly-
substance use affects personality functioning among Norwegian SUD patients. Thus, SUD 
patients with poly-substance use are expected to have lower scores on all SIPP-118 domains 
compared to patients that primarily prefer using only one substance. 
b. Injecting use is associated with higher rates of morbidity and mortality compared to 
other routes of administration, as well as poorer mental and physical health, and some 
researchers propose that injecting substance use is a separate indicator of more severe 
psychopathology (Saint-Lebes et al., 2012). We expect this to be reflected in the levels of 
severity of the Norwegian SUD patients included in the study. We expect to find that patients 
with injection as primary route of administration and patients preferring multiple routes of 
administration have lower scores on all domains of the SIPP-118 than non-injectors. 
c. Trenz et al. (2012) emphasize the importance of exploring early substance use debut, 
particularly at or prior to age 15. Kandel, Davies, Karus, and Yamaguchi (1986) found that 
substance use at age 15-16, primarily use of illicit substances, correlated with continued 
substance use, marital problems, work instability, delinquency and psychological functioning 
10 years later. In accordance with this and other studies showing detrimental long-term effects 
of early substance use initiation, we expect to find that patients reporting substance use debut 
before or at the age of 16 will have lower scores on all SIPP-118 domains compared to 
patients with substance use debut at older ages, indicating an association between age of 
debut and personality problem severity. 
d. SUD patients are often characterized by and divided according to primary preferred 
substances. The division between alcohol as preferred substance and other preferred 
substances is especially pronounced. Several studies have found that there are significantly 
lower rates of PDs among substance users primarily using alcohol than among those using 
other substances (Landheim et al., 2003; Langås et al., 2012; Skodol et al., 1999). Preferring 
alcohol compared to preferring other substances might relate differently to severity of 
personality problems. More specifically, we expect to find more severe personality problems 
among SUD patients using other substances compared to those primarily using alcohol. In 
 10 
 
accordance with Campbell et al. (2013), showing that primary substance of use is an 
unimportant indicator of substance use severity; we do not expect to find significant 
differences in severity of personality problems between SUD patients based on primary 
preferred substance of use. 
3. Landheim et al. (2003) found significant differences in comorbidity rates and patterns 
between male and female poly-substance users. The female substance users had higher rates 
of BPD, while the male poly-substance users more often met diagnostic criteria for ASPD. In 
the study by Arnevik et al. (2009) where severity of personality problems among PD patients 
was investigated, no significant differences between genders were found. In the present study, 
we are concerned with severity of personality problems; core pathology common across PDs. 
Thus, no significant differences in SIPP-118 domain scores between genders are expected. 
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2 Method 
2.1 Sample 
The sample consists of inpatients at the section for detoxification from alcohol and other legal 
substances, and section for illegal substances at the Oslo University Hospital. Before 
admission to treatment patients are evaluated by an interdisciplinary team. Patients who fulfill 
the diagnostic criteria for SUDs according to the diagnostic system ICD-10, are given “right” 
to specialist health care treatment according to the national “Prioriteringsveileder Tverrfaglig 
Spesialisert Rusbehandling (TSB)” (Helsedirektoratet, 2012b). Thus, all the study participants 
were admitted to specialist health care treatment. 
2.2 Participant characteristics 
The sample consists of 155 participants, with a mean age of 42 years (SD=11.7). 61% of the 
participants were men, 66% had 12 years of education or more, and 26% had completed a 
university or a university college education (see table 1). 
30% of the sample reported alcohol as their primary preferred substance, 20% heroin, 6% 
amphetamines, 3% medicines/pills, 3% cannabis, 2% cocaine, 1% Methadone/Subutex, 1% 
other opiates and 1% hallucinogens. One third of the sample reported multiple primary 
substances. The sample was divided into five subgroups for statistical analyses, based on the 
nature of their primary preferred substance (Campbell et al., 2013; Fridell & Hesse, 2006). 
These five groups were alcohol, opiates (heroin, Methadone/Subutex and other opiates), 
stimulants (amphetamines, cocaine and cannabis (Stewart, Dewit, & Eikelboom, 1984)), 
tranquilizers (medicines/pills) and other substances (see table 1). The majority of the last 
group (52 of 53) reported preferring multiple substances, indicating poly-substance use. 
Two thirds of the sample (62.5%) reported daily poly-substance use. Similar portions of SUD 
patients with poly-substance use have been found in other studies (European Monitoring 
Centre for Drugs and Drug Addiction, 2009). With regard to route of administration for 
primary preferred substance, 36.5% of the sample reported oral administration, 6% nasal 
administration, 13% smoking, 3% non-intravenous injection, 29% intravenous injection, and 
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13% reported multiple routes of administration. 62% of the total sample reported that they 
had once injected a substance. Mean age for injection debut was 23 years (SD=8.6). 
Based on reviewed literature on consequences of age of substance use debut, it seems relevant 
whether debut happens before or after 16 years of age (Kandel et al., 1986). Because the 
majority (74%) of the present sample reported substance use before or at age 16, this group 
was divided into two subgroups to be able to further check for impact. Age of debut within 
the sample varied between 7 and 52 years, with a mean age of 16 years (SD= 6.6). Age of 
substance use debut was split into three groups for analyses: very low age of debut (earliest 
age (7 years) 13 years) (37,5%), low age of debut (14-16 years) (37,5%) and moderate to 
high age of debut (17 years  oldest (52 years)) (23%). 
Because of limited time and resources, as well as concerns regarding accuracy of self-report, 
no data on co-occurring axis I pathology was collected for the present study. A number of 
previous studies have found that there is a high prevalence of mental disorders; mood 
disorders, anxiety and post-traumatic stress disorder, as well as PDs, among SUD patients in 
treatment (Conway, Kane, Ball, Poling, & Rounsaville, 2003; Flynn & Brown, 2008; 
Folkehelseinstituttet, 2014). This means that several of the participants in the study might 
have a co-occurring axis I mental disorder. 
Table 1: Characteristics of the study participants. 
Characteristic  N (%) 
Gender, male 94 (61) 
Education, 12 years or more  101 (66) 
Preferred substance  
Alcohol 46 (30) 
Opiates 34 (22) 
Stimulants 17 (11) 
Tranquilizers 5 (3) 
Other/multiple 53 (34) 
Poly-substance use 90 (62,5)    
Route of administration 
 Oral 51 (36) 
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Nasal 9 (6) 
Smoking 18 (13) 
Non-intravenous injection 4 (3) 
Intravenous injection 41 (29) 
Multiple 18 (13) 
Age of debut 
 7  13 58 (38) 
14  16  58 (38) 
17  36 (24) 
2.3 Data collecting procedure and context 
Questionnaire data was gathered in a period of seven months, from July 2014 to January 
2015. Research protocol was approved by the Regional Ethics Committee (REK) prior to data 
collection. 
Participants were recruited through weekly participation at collective afternoon meetings at 
the two detoxification sections. During these meetings patients were given brief information 
about the study and participation. It was promoted as a study to look into the needs and 
problem areas of patients in SUD treatment, with the objective of further insight into how we 
can improve SUD treatment. The staff working at the three sections was also encouraged to 
recruit participants. No incentive was offered, and the voluntary nature of participation was 
emphasized. Patients were informed that choice of participation would have no consequences 
for further or current treatment (Del Boca & Noll, 2000). Patients with insufficient command 
of the Norwegian language, in acute crisis or other severe condition were not requested to 
participate. Patients were asked to fill out the questionnaire either on their own or with help 
from the staff. The filled out questionnaires were put in marked envelopes, which were in turn 
put in a locked mailbox. All data was treated without name, national identity number or other 
pieces of identifying information.  
The description of the context is relevant when discussing the results, as the context might 
affect the validity of the assessment. The usual length of treatment at the detoxification 
sections is approximately 10 days. Many patients are referred for further SUD treatment after 
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this. For some patients, this is their first encounter with SUD treatment, while other patients 
have been through several earlier detoxification stays as well as longer duration treatments. 
One of the things that these patients share is that this is a challenging period, characterized by 
upheavals, changes, and insecurity. The two detoxification sections each have 15 beds, and 
patients are replaced each day, making the patient group unstable. It is reasonable to reflect on 
the impact this environment has on patients in which a large portion might have insecure 
attachment patterns (Thorberg & Lyvers, 2006). In addition an unstable external context, 
many of the detoxification patients may struggle with abstinence pains, withdrawal symptoms 
and other physical problems due to recent substance use, which impact their functioning. 
During time of collection, there was opportunity to spend time and engage in dialogue with 
the patients. Regardless of their choice of participation, the majority of patients expressed a 
positive attitude towards the study. Several patients expressed the wish to talk about their 
history and present situation, plans for further treatment and to express personal opinions on 
how SUD treatment can improve, often mentioning the need for a well-functioning follow-up 
care. While some patients displayed an uncritical openness, others kept their distance and 
explained that they refused to participate because they did not want to give out personal 
information. A large portion of the patients asked did not want to participate, often because 
they found the questionnaire too extensive and too long. Due to the study design, we do not 
have information on the group of patients declining to participate. 
2.4 Design and questionnaire 
The study used a cross-sectional design that was based on self-report questionnaires. The 
questionnaire (see appendix) was developed for the current study to be able to answer the 
research questions of interest. Total number of items in the questionnaire was 133. The main 
part of the questionnaire was the Severity Indices of Personality Problems (SIPP-118), used in 
the operationalization of personality problems. Five questions concerned demographic data 
such as gender, age and level of education. The last 10 questions were adapted from the 
widely used questionnaire European Addiction Severity Index (EuropASI) (Kokkevi et al., 
1994), which was used as a basis to assess substance use characteristics. 
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2.5 Operationalization of personality problems 
Personality problems were assessed using the SIPP-118. The SIPP-118 is a self-report 
questionnaire developed by Dutch and British clinical experts in the field of personality and 
PDs (Verheul et al., 2008). The questionnaire was primarily developed for research purposes, 
but seems to be useful in clinical contexts (Andrea et al., 2007). The SIPP-118 assesses the 
personality problem profile of a given individual, and the severity of these personality 
problems. The perspective underlying the SIPP-118 is based on dimensional approaches to 
core components of personality pathology rather than type-based classification systems. As 
the focus of the measure is on adaptive capacities considered subject to change (Bastiaansen 
et al., 2013), the SIPP-118 can be administered as a repeated measure of change after 
therapeutic interventions (Verheul et al., 2008). 
The 16 facets outlined in table 2 are the basis of the SIPP-118. They make up five domains of 
personality functioning; self-control, identity integration, responsibility, relational functioning 
and social concordance. The 16 facets are unidimensional, generalizable across various types 
of PDs, have good internal consistency and have shown good test-retest reliability (Andrea et 
al., 2007; Verheul et al., 2008). 
Table 2: Facets and domains of the SIPP-118. 
Facet Domain 
Emotion regulation Self-control 
Effortful control 
 Self-respect Identity integration 
Stable self-image 
 Self-reflexive functioning 
 Enjoyment 
 Purposefulness 
 Responsible industry Responsibility 
Trustworthiness 
 Intimacy Relational functioning 
Enduring relationships 
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Feeling recognized 
 Aggression regulation Social concordance 
Frustration tolerance 
 Cooperation 
 Respect 
  
The SIPP-118 asks respondents to rate the extent to which they agree on 118 different 
statements when thinking back on the last three months. Examples of statements are: “I know 
exactly who I am and what I am worth” and “Some people think of me as a rude person”. 
Response is scored on a 4-point Likert scale, ranging from 1 (“completely disagree”) to 4 
(“completely agree”). High scores on the SIPP-118 indicate higher levels of adaptive 
capacities, whereas lower scores indicate deficient levels of adaptive capacities and thus 
personality problems (Andrea et al., 2007). For the current study, a version of the SIPP-118 
translated to Norwegian was used, showing good reliability at the facet level and good cross-
national validity when used with a Norwegian PD patient sample (Arnevik et al., 2009). 
2.6 Operationalization of substance use 
characteristics 
Questions concerning the participant’s substance use characteristics were drawn from the 
European adaptation of the fifth edition of the Addiction Severity Index (EuropASI) (Kokkevi 
& Hartgers, 1995). The EuropASI is a semi-structured interview examining problems and 
symptoms in seven areas of functioning assumed to be affected by substance use and subject 
to change during treatment. The areas are medical condition, employment/social support, 
alcohol consumption, consumption of other substances, legal problems, family/social 
relationships and psychological condition (Kokkevi & Hartgers, 1995; López-Goñi, 
Fernández-Montalvo, & Arteaga, 2012). The EuropASI is used clinically to assess individual 
treatment needs and also for research purposes, such as comparing groups of SUD patients 
with different characteristics (López-Goñi et al., 2012). Studies of the reliability and validity 
of the EuropASI have been conducted on SUD populations with satisfactory results (Kokkevi 
& Hartgers, 1995). 
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Questions from the section covering consumption of alcohol and other substances in the 
EuropASI were turned into questionnaire format and included in the study questionnaire. 
Questions were chosen on the basis of their relevance for the research questions, and how 
substance use severity is operationalized elsewhere (Fernandez-Serrano, Lozano, Perez-
Garcia, & Verdejo-Garcia, 2010; Gonzales et al., 2011). Included questions concerned age of 
substance use debut, primary and secondary preferred substance, poly-substance use, route of 
administration, age of injection debut, longest period of abstinence and previous treatments 
(see appendix). The majority of these questions correspond to definitions of the same 
constructs elsewhere, while others are more difficult to reach an agreement on. One construct 
difficult to define is poly-substance use. The European Monitoring Centre for Drugs and Drug 
Addiction (2009) has defined poly-substance use as “regular use of more than one substance”, 
while the same construct is defined by EuropASI as “daily use of more than one substance”, 
making comparisons between studies difficult. In this study, the definition from the EuropASI 
was adopted. 
2.7 Statistical analyses 
For investigating the present hypotheses, a quantitative approach was chosen. Data was 
analyzed using the Statistical Program for Social Sciences (SPSS, version 22.0). All predictor 
and criterion variables represent psychological constructs operationalized on the basis of the 
study questionnaire. All statistical tests were two-tailed, and we employed an alpha level of 
.05. 
Before conducting analyses, the assumption of normality in the data was explored. Normally 
distributed continuous variables are an underlying assumption for subsequent tests (Field, 
2009). The histograms in figure 1 show frequency (y-axis) and score (x-axis) on the five 
SIPP-118 domains. From visual inspection, the scores look reasonably normally distributed, 
following the shape of the normal curve. Scores of skewness and kurtosis were calculated. 
Skewness and kurtosis are measures of the distributions’ symmetry and pointiness, and large 
scores indicate that the data are not normally distributed (Field, 2009). In the current sample 
skewness scores for the five domains were within the range of .35 and 2.38, and kurtosis 
scores within the range of .42 and 1.41. This is considered acceptable. In summary, there were 
no serious violations of the assumption of normality in the five outcome variables. Thus, 
parametric tests were preferred for subsequent analyses. 
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Figure 1: Distribution of scores on the criterion variables; the five SIPP-118 domains. 
1 2 3 4 5
Note: 1 Self-control, 2 Social concordance, 3 Identity integration, 4 Relational functioning and 5 Responsibility. 
 
To compare severity of personality problems in the study sample to two PD samples and a 
sample from the normal population, analysis of variance (ANOVA) for each facet of the 
SIPP-118 was conducted. The data available for conducting these ANOVAs were sample 
size, mean and standard deviation (SD) retrieved from Andrea et al. (2007) and Arnevik et al. 
(2009), thus we conducted ANOVAs using summary data. As SPSS cannot be used for 
conducting these analyses, an online calculator was used (Interactive Statistics, 2015). To test 
where reliable differences between samples occurred, Tukey HSD post-hoc tests were 
executed. The Tukey HSD is a less conservative test than the Bonferroni correction. This 
means that it is easier to achieve statistical significance with the Tukey HSD than with more 
conservative corrections, which in turn might lead to overestimation of the differences 
between the samples in the analysis (Bordens & Abbott, 2008).  To further compare SIPP-118 
facet scores between the different samples, effect sizes were calculated. Because of 
limitations regarding available data for conducting the analyses (sample size, mean and SD), 
we calculated Cohen’s d using an online effect size calculator (Psychometrica, 2015).  
According to Cohen (1992), d = .10 is considered a small, .50 medium and 1.0  a large effect 
size. 
For investigating the hypotheses concerning whether severity of personality problems in the 
sample significantly varied across substance use characteristics, we conducted independent 
samples t-tests and ANOVAs. ANOVA is a robust statistical test, not highly affected by 
different sizes between samples or violations of underlying statistical assumptions (Bordens 
& Abbott, 2008). For post-hoc tests, the Bonferroni correction was chosen. This is a 
conservative test, thus reducing the chance of finding statistically significant differences only 
by chance; type I errors. The trade-off with using the Bonferroni correction is loss of 
statistical power, meaning a somewhat lower chance of detecting a true effect (Field, 2009). 
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To explore whether indicators of substance use severity predicted severity of personality 
problems, a multiple regression analysis was conducted. The method of forced entry (enter in 
SPSS) was chosen, as the predictor variables seem to be somewhat independent predictors of 
substance use severity, and therefore independently related to the outcome variable. 
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3 Results 
3.1 Reliability 
Reliability analyses were conducted to investigate the consistency between the items included 
in the 16 facets of the SIPP-118, and was estimated using Cronbach’s alpha (α). The facets 
showed alpha scores from 0.59 to 0.84, with a mean estimated alpha score of 0.74 (see table 
3). The facets showing alpha scores below 0.70, indicating low to moderate reliability, were 
intimacy (α=0.59), enduring relationships (α=0.69), responsible industry (α=0.68) and respect 
(α=0.62). 
Table 3: Reliability of the 16 SIPP-118 facets for three different samples. 
  Cronbach’s alpha (α)   
Facets Number of 
items 
Norwegian substance 
use population 
Dutch normal 
population 
Dutch PD 
population 
Emotion regulation 7 0.76 0.82 0.74 
Effortful control 7 0.72 0.72 0.79 
Self-respect 8 0.80 0.83 0.81 
Stable self-image 7 0.76 0.82 0.74 
Self-reflexive functioning 7 0.80 0.81 0.74 
Enjoyment 7 0.75 0.79 0.75 
Purposefulness 7 0.79 0.74 0.74 
Intimacy 7 0.59 0.83 0.80 
Enduring relationships 7 0.69 0.75 0.73 
Feeling recognized 8 0.77 0.80 0.77 
Responsible industry 7 0.68 0.68 0.73 
Trustworthiness  8 0.70 0.69 0.78 
Aggression regulation  8 0.84 0.79 0.86 
Frustration tolerance 8 0.78 0.78 0.73 
Cooperation 8 0.76 0.76 0.76 
Respect 7 0.62 0.65 0.69 
Note: Low alpha scores are indicated with bold writing.  
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3.2 Personality problems among SUD patients 
Figure 2 presents SIPP-118 facet scores for the study sample (N=155) compared to a 
Norwegian PD sample (N=114) (Arnevik et al., 2009), a Dutch PD sample (N=555) and a 
sample from the Dutch normal population (N=478) (Andrea et al., 2007). 
Figure 2: Mean scores for the 16 SIPP-118 facets in four different samples.
 
3.2.1 Comparing personality problem severity between different 
samples 
One-way ANOVAs were conducted to explore whether scores on the 16 SIPP-118 facets 
differed between the four different samples; Norwegian SUD patients, Norwegian PD 
patients, Dutch PD patients and the Dutch normal population. Tukey post-hoc tests showed 
that the difference between facet scores in the SUD patient sample and the Dutch normal 
population sample were statistically significant (p<.001) for the following 14 facets; emotion 
regulation, self-respect, stable self-image, self-reflexive functioning, enjoyment, 
purposefulness, intimacy, enduring relationships, feeling recognized, trustworthiness, 
aggression regulation, frustration tolerance, cooperation and respect. 
To further explore the differences in personality problem severity between the samples, we 
calculated effect sizes using the Cohen’s d. Effect size for all 16 SIPP-118 facets between the 
sample of SUD patients and the Norwegian PD sample, and between the SUD sample and the 
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sample from the Dutch normal population, were calculated (see table 4). As seen in figure 2, 
the SUD sample differed from the Dutch normal population sample on a majority of the 
facets, with effect sizes (Cohen’s d) ranging from 0.28 to 1.92. The mean estimated effect size 
for all facets was 1.06. Comparatively, when looking at the scores between the study sample 
and Norwegian PD sample, these were similar on a majority of the facets. Effect sizes 
between these two samples had a range from 0.02 to 0.73, with a mean estimated effect size 
for all facets of 0.38. 
Table 4: Effect sizes (Cohen’s d) between the sample of SUD patients and PD patients and 
between SUD patients and normal population sample. 
 
Cohen’s d 
   
Facet  SUD vs. PD (Norway) 
SUD vs. normal (the 
Netherlands) 
Emotion regulation 0.345 1.152 
  Effortful control 0.016 1.481 
  Self-respect 0.693 1.068 
  Stable self-image 0.435 1.000 
  Self-reflexive functioning 0.353 1.078 
  Enjoyment 0.616 1.207 
  Purposefulness 0.529 1.389 
  Intimacy 0.348 0.480 
  Enduring relationships 0.730 0.840 
  Feeling recognized 0.511 0.643 
  Responsible industry 0.295 1.920 
  Trustworthiness 0.313 1.691 
  Aggression regulation 0.056 1.184 
  Frustration tolerance 0.493 1.078 
  Cooperation 0.426 0.511 
  Respect 0.062 0.278 
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3.3 The relationship between substance use 
characteristics and severity of personality problems 
We explored whether the presence of poly-substance use was related to severity of personality 
problems in the sample. 62% of the sample (N=89) reported poly-substance use. The poly-
substance group had lower mean scores on all five SIPP-118 domains than the non-poly-
substance group (see figure 3). This difference was statistically significant for four of the five 
domains; self-control (t(140)= -3.036, p <.01), social concordance (t(141)=-2.030, p<.05), 
identity integration (t(141)=-2.885, p<.01) and relational functioning (t(141)=-2.361, p<.05). 
The difference was not statistically significant for the responsibility domain. 
Figure 3: Mean scores on the five SIPP-118 domains for patients reporting poly-substance 
use and patients not reporting poly-substance use. 
 
44% of the sample (N=61) reported injection (intravenous or not intravenous) as usual route 
of administration, or multiple routes of administration. The part of the sample reporting 
injecting/multiple routes had lower mean scores on all SIPP-118 domains than the non-
injecting group (see figure 4). This difference was statistically significant only for the self-
control domain (t(137)=-1.967, p <.05).  
 
 
 
 
0,00
1,00
2,00
3,00
4,00
5,00
6,00
Self-control Social
concordance
Identity
integration
Relational
functioning
Responsibility
Poly-substance use (N=89)
No poly-substance use (N=54)
 24 
 
Figure 4: Mean SIPP-118 domain scores for patients reporting injection or multiple routes as 
preferred route of administration and patients reporting other routes of administration. 
 
Age of debut was divided into three groups; very low age of substance use debut (very low 
age of debut (7 years) 13 years) (37,5%), low age of debut (14-16 years) (37,5%) and 
moderate to high age of debut (17 years  oldest) (23%). Across all SIPP-118 domains, 
patients with very low and low age of substance use debut had lower mean scores than 
patients with debut at moderate or high ages (see figure 5). Post-hoc comparisons with the 
Bonferroni correction were conducted to check for further patterns in the results. These 
analyses showed that the difference between scores for the low age groups and the 
moderate/high age group was statistically significant on three domains; self-control 
(F(2,147)=6.214, p<.01), identity integration (F(2,148)=6.568, p<.01) and responsibility 
(F(2,147)=4.278, p<.05). Difference in scores between the very low and low age of debut 
groups were not statistically significant for any of the domains.  
Figure 5: Mean domain scores between ages of substance use debut.
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30% of the sample (N=46) reported alcohol as their primary preferred substance of use, with 
the remaining 70% (N=107) of the sample reporting other or multiple preferred substances. 
Independent samples t-tests showed that the group reporting alcohol as primary preferred 
substance had higher mean scores on all domains than the remainder of the sample (see figure 
6). This difference was statistically significant for the domains self-control (t(151)= -2.053, p 
<.05), identity integration (t(152)= -2.188, p <.05) and responsibility (t(151)= -2.398, p <.05).  
Figure 6: Mean SIPP-118 domain scores for patients primarily preferring alcohol and 
patients preferring other substances. 
 
The further effect of primary preferred substance on severity of personality problems was 
explored using one-way between groups ANOVA. Preferred substance of use was grouped 
into five categories; alcohol (N=46), opiates (N=34), stimulants (N=17), tranquilizers (N=5) 
and multiple/other (N=53). The group of patients reporting alcohol as their preferred 
substance had higher scores across all SIPP-118 domains compared to the four other 
categories (see figure 7), but this difference was not statistically significant for any of the 
domains. Post-hoc comparisons with the Bonferroni correction showed no statistically 
significant differences in domain scores based on preferred substance.  
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Figure 7: Mean domain scores between different primary preferred substances of use. 
 
The effect of gender on severity of personality problems was explored using independent 
samples t-tests. There was no consistent trend across gender in the mean domain scores. 
However, the female part of the sample (39%) had statistically significant higher scores on 
the social concordance domain (t(151)=-2.342, p <.05) and the responsibility domain 
(t(150)=3.457, p <.01), than the male part. 
3.4 Multiple regression 
A multiple linear regression was conducted to investigate whether SIPP-118 domain scores 
could be predicted by substance use characteristics. Before conducting the analysis, 
underlying assumptions for multiple regression was explored (Field, 2009). First, we 
conducted a bivariate correlation between possible predictor variables (see table 5). 
Table 5: Bivariate correlations between possible predictor variables. 
 
Poly-substance 
use Age of debut 
Preferred 
substance 
Alcohol vs 
other 
Age of debut .173* 
   Preferred substance -.445** .071 
  Alcohol vs other  -.544** -.120 .758** 
 Injection/multi use -.427** -.256** .309** .523** 
 
   
Note: **p<.01, *p<.05 
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The highest correlation between predictor variables, r= -.758, was found between the two 
variables concerning preferred substances; “preferred substance” and “alcohol vs other”. In 
accordance with statistic guidelines to avoid problems of multicollinearity (Bordens & 
Abbott, 2008), we chose to eliminate the variable “preferred substance”. Moderately high 
correlations were found between the variables “preferred substance” and “poly-substance 
use”, however both variables were kept for further analyses. Preliminary analyses showed a 
sufficiently large sample size, no multicollinearity between predictor variables, normally 
distributed as well as linear residuals, and no detected outliers. As there were no serious 
violations of basic assumptions, the regression analysis was conducted. 
Three predictor variables; primary substance of use (alcohol vs. other), age of debut (>16 vs. 
<&16) and poly-substance use (no vs. yes), was included in the analysis. Evident from the 
conducted t-tests and ANOVAs, these showed a statistically significant association with the 
criterion variables. Route of administration was not included, as this factor’s association with 
severity of personality problems in the study sample was not statistically significant. 
The results of the regression indicated that the three predictors explained 12,3% of the 
variance in self-control domain score (R² =.123, F(3,138) = 6,462, p<.001), 4% of the 
variance of score on the social concordance domain (R² = .040, F (3,139) = 1,932, n.s.), 
12,4% of the variance of the score on the identity integration domain (R² = .124 F(3,139) = 
6,537, p<.001), 5,6% of the variance in relational functioning score (R² = .056, F(3,139) = 
2,769, p<.05), and 8,4% of the variance in responsibility domain score (R² = .084, F(3,138) = 
4,245, p<.01) (see table 6). Age of debut was found to be a statistically significant predictor of 
SIPP-118 score on three domains; self-control, identity integration and responsibility. Poly-
substance use was found to predict domain score to a lesser degree; the variable explained a 
statistically significant amount of variance for the two domains self-control and relational 
functioning. Primary substance of use (alcohol vs other/multiple substances) was a non-
statistically significant predictor of score on all of the domains in the SIPP-118. 
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Table 6: Regression analysis predicting domain score on SIPP-118 from type of primary 
substance of use (alcohol or other), age of debut and poly-substance use. 
Dependent variable Independent variable Model R ² β t Sign. 
Self-control 
 
.123 
 
13.566 
 
 
Alcohol vs other  
 
-.064 -.677 .500 
 
Age of debut 
 
-.245** -3.058 .003 
 
Poly-substance use 
 
-.190* -1.990 .049 
Social concordance 
 
.040 
 
15.423 
 
 
Alcohol vs other  
 
.041 .416 .678 
 
Age of debut  
 
-.101 -1.213 .227 
 
Poly-substance use 
 
-.181 -1.815 .072 
Identity integration 
 
.124 
 
13.335 
 
 
Alcohol vs other  
 
-.066 -.703 .483 
 
Age of debut  
 
-.258** -3.230 .002 
 
Poly-substance use 
 
-.174 -1.830 .069 
Relational functioning 
 
.056 
 
13.835 
 
 
Alcohol vs other 
 
.042 .425 .672 
 
Age of debut 
 
-.130 -1.571 .118 
 
Poly-substance use 
 
-.205* -2.073 .040 
Responsibility 
 
.084 
 
13.521 
 
 
Alcohol vs other  
 
-.145 -1.492 .138 
 
Age of debut  
 
-.225** -2.743 .007 
 
Poly-substance use 
 
-.047 -.488 .627 
Note: ** p<.01, * p<.05. 
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4 Discussion  
4.1 Personality problems among SUD patients 
The aim of the study was to investigate personality problems, as measured by the SIPP-118, 
among SUD patients. In agreement with our expectations, we found that the SUD patient 
sample had severe personality problems. Our main findings are in accordance with several 
studies showing high prevalence of personality pathology among patients in SUD treatment 
(Grant et al., 2004; Skodol et al., 1999). The fact that our study’s findings correspond to 
results from studies with larger samples and more extensive methods strengthens our 
findings’ trustworthiness and generalizability, and indicate that personality problems might be 
measured early in a treatment process, assessed by self-report measures. This might have 
important clinical implications, as will be discussed later. 
An underlying assumption of the SIPP-118 is that it is a measure of core personality 
pathology (Andrea et al., 2007). Our main findings being in accordance with accredited 
studies showing high SUD-PD co-occurrence strengthens this assumption. In the current 
study, we compared SIPP-118 scores from our study population with three different samples; 
two samples of PD patients and one normal population sample. In agreement with our 
expectations we found an overlapping facet profile and comparable facet scores, as indicated 
by low to moderate effect sizes, between a Norwegian PD sample (Arnevik et al., 2009) and 
the Norwegian SUD sample. We found that SUD patients’ scores were significantly different 
from the scores of the Dutch normal population sample on the majority of the 16 SIPP-118 
facets, as well as a large mean effect size on all facets between these samples.  Thus, our 
results indicate that SUD patients have personality problems at a level of severity comparable 
to PD patients, and significantly different from the normal population. The results strengthen 
the assumption that the SIPP-118 is a measure of pathology, which means that the 
questionnaire measures what it was intended to measure. 
A premise for answering the questions of interest is adequate psychometric properties of the 
SIPP-118 when used with the study sample. The SIPP-118 has not previously been used with 
SUD patient samples. Furthermore, personality pathology in our study sample was assessed 
during the detoxification stage despite the general assumption that personality pathology 
should be assessed in a stable phase after months of abstinence. Both factors could affect the 
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questionnaire’s ability to assess personality problems reliably and validly in the study sample. 
When exploring the reliability of the SIPP-118, we found moderate to high alpha levels for 
the majority of the SIPP-118 facets.  Cronbach’s alphas in the current study were in the same 
range as with the Dutch normal and PD sample and the Norwegian PD sample (Arnevik et al., 
2009). Thus, the results indicate that the SIPP-118 reliably assess personality functioning in 
SUD patients during detoxification.  
Our findings strengthen the assumption that personality problems are a common feature 
among SUD patients. This appears to be a robust finding, though many questions concerning 
personality problems within this patient group remain. For example, the impact of withdrawal 
states and abstinences on personality problems should be the subject of investigation. A 
longitudinal study, measuring SUD patients’ personality problems in the abstinence phase and 
then again in later stages of treatment, or years after treatment completion, would be a useful 
supplement to the existing literature. This would inform us about the stability and change of 
personality problems among SUD patients, and whether level of severity is unstable due to 
effects of withdrawal, effects of substance use or change due to treatment. This might also 
shed light on the etiology of the co-occurrence between SUDs and PDs.  
4.2 Characteristics of substance use related to 
severity of personality problems 
For the purpose of exploring how severity of substance use relates to personality problems, 
we investigated the association between poly-substance use, injecting use, early age of debut 
and primary preferred substance of use not being alcohol, and personality problem severity. 
These characteristics are commonly considered indicators of substance use severity, and are 
related to negative long-term consequences for mental and physical health (Colpaert et al., 
2013; Gonzales et al., 2011).  
It is generally acknowledged that poly-substance use indicates a more severe pattern of 
substance use, and has a wide range of negative consequences (Di Poggio et al., 2006; 
European Monitoring Centre for Drugs and Drug Addiction, 2009). In agreement with this, 
we found that the group of participants who reported poly-substance use had more severe 
personality problems than those who reported using only one substance per day. The direction 
of this relationship is unclear. The nature of poly-substance use itself might account for the 
high levels of personality problems in this group. For example, the increased toxicity resulting 
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from interactions between substances consumed close together in time or the possible 
consumption of higher doses of substances (European Monitoring Centre for Drugs and Drug 
Addiction, 2009), might lead to more severe personality problems found among poly-
substance users. Another possibility is that patients with more severe underlying personality 
problems and relational problems might be more susceptible for poly-substance use, thus 
creating the association.  
Based on research showing that injecting substance use has detrimental consequences for 
mental and physical health (Domier et al., 2000; European Monitoring Centre for Drugs and 
Drug Addiction, 2014; Strang et al., 1998), it was somewhat surprising to find that injection 
use was not related to severity of personality problems in the study sample. However, only a 
small portion of the reviewed literature investigated injection use in Norwegian settings. 
Injecting substance use might be perceived as less severe, and have less severe consequences, 
among Norwegian substance users than elsewhere, which might help explain the weak 
association we found. Injection use is a common route of administration in Norway. In our 
study sample, two thirds of the participants reported having once injected a substance. In a 
study by SIRUS (2014a), 80% of the sample (only including non-alcohol using participants) 
reported having injected a substance during the last four weeks. While there has been little 
research on injecting substance users in Norway, the problem has had political focus for 
years. This led to the establishment of a safer injection facility (SIF) in Oslo in 2005. The SIF 
is a place where injection users can get temporary shelter, clean syringes and medical help if 
needed (SIRUS, 2014b). Reviews find that SIFs lead to less risky injecting behavior, fewer 
deaths due to overdoses, increased enrollment in SUD treatment and saved public resources 
(Beletsky, Davis, Anderson, & Burris, 2008; Petrar et al., 2007). The impact of injection use 
among Norwegian substance users for personality functioning and other aspects of mental 
health should be the subject of further investigation. 
We found that substance use before or at age 16 was related to severity of personality 
problems. This corresponds to the general agreement within the SUD field that early debut of 
substance use is a risk factor for severe dependence (Gruber et al., 1996; Magid & Moreland, 
2014; Trenz et al., 2012), and that early substance use can affect personality functioning 
(Kandel et al., 1986; Trenz et al., 2012). High levels of personality problems may lead to an 
earlier substance use debut, early involvement in substance use may lead to lower 
functioning, or both processes might be involved. This study does not clarify the link of 
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causality further, but it illustrates the importance of early intervention and good prevention 
strategies. An interesting topic for further research is looking into the relationship between the 
particular substance used at debut and personality problems. A plausible hypothesis would be 
that early debut with heroin or other illegal substances would be indicative of more severe 
personality pathology than early debut with cigarettes or alcohol. Understanding these 
relationships is important to create efficient prevention and intervention strategies. 
As SUD patients are often classified based on whether their primary preferred substance of 
use is alcohol or other substances, we wanted to explore whether this was related to severity 
of personality problems. In our study sample, using other substances than alcohol was 
associated with more severe personality problems. This is in agreement with studies finding 
lower rates of PDs among SUD patients primarily using alcohol compared to those using 
other or multiple substances (Grant et al., 2004). The association between alcohol and 
personality problems might indicate that using alcohol is generally less harmful for 
personality functioning than using other or multiple substances. If this is not the case, it might 
indicate that there are other moderating or mediating variables accounting for the relationship. 
Possible variables may concern patient characteristics such as age, poly-substance 
involvement, age of harmful use/dependence onset or education level. 
4.2.1 Can we use characteristics of substance use as a tool to 
screen for personality problems? 
We conducted a regression analysis to explore which, if any, of the characteristics of 
substance use could predict severity of personality problems. Only the three variables poly-
substance use, early age of debut and primary preferred substance other than alcohol was 
included. We found age of debut and poly-substance use to be statistically significant 
predictors, while primarily using alcohol did not significantly predict personality problem 
severity. Thus, we might be left with two separate substance use characteristics predicting the 
severity of personality problems in the study sample; patients with substance use debut before 
or at the age of 16 and patients using multiple substances daily. 
Even if age of debut and poly-substance use were the substance use characteristics with the 
highest explanatory value in this study, these variables explained only a small portion (4 to 
12%) of the variance in severity of personality problems. This means that none of the 
common indicators of substance use severity can be used to explain the presence and severity 
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of personality problems in the investigated SUD sample. A more general conclusion is that 
personality problem severity might not be explained by characteristics of substance use. 
Furthermore, this might indicate that one cannot clinically screen for personality pathology in 
SUD patients by substance use characteristics alone. There may be no apparent short-cut for 
assessing personality problems in this clinical population, indicating the importance of 
independently assessing personality problems in SUD patients.     
4.3 Limitations and strengths 
Several limitations of the current study should be acknowledged. The first limitation concerns 
the fact that the study is based on self-report questionnaires, with respect to both personality 
problems and substance use characteristics. There are certain drawbacks with using self-report 
instruments. One is the assumption that participants give correct and accurate answers to most 
items for our data to be valid. Darke (1998) has suggested that self-report is a reliable and 
valid method of retrospectively reporting substance use. While the questions concerning 
substance use characteristics are of a more factual nature, the questions concerning 
personality functioning depends on abilities to introspect. The self-report questionnaire 
assumes that the individual has expertise and self-knowledge enough to report subtle as well 
as more apparent dimensions of themselves correctly. If participants incorrectly report aspects 
of their personality functioning, this might lead to an overestimation or underestimation of 
their personality problems. 
A common challenge in using self-report questionnaires is that the statistical properties differ 
in different patient populations. Illustrative of this is a German study of the validity of the 
Symptom Checklist-90 (SCL-90), where the instrument showed better psychometric 
properties when used with clinical rather than nonclinical samples (Schmitz et al., 2000). In 
another validity study of the SCL-90 in Finland (Holi, Sammallahti, & Aalberg, 1998), they 
found that the American norms were invalid in Finnish settings. Similarly, we are faced with 
questions regarding whether the psychometric properties of the SIPP-118 differ when used 
with the study sample compared to other samples. Previous studies investigating the use of 
the SIPP-118 with a sample from the normal population, PD samples, and clinical and non-
clinical adolescent samples (Andrea et al., 2007; Arnevik et al., 2009; Feenstra et al., 2011; 
Verheul et al., 2008), have found good psychometric properties of the instrument, including 
high alpha levels for the majority of the 16 SIPP-118 facets. This is the first study 
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investigating the use of the SIPP-118 in a sample of adult, Norwegian SUD patients. 
Therefore, we investigated the validity and reliability of the questionnaire. 
When investigating the psychometric properties of a questionnaire, questions concerning how 
items are perceived by the sample, in what context the questions are reflected upon and how 
concepts are understood by the participants are relevant (DeVellis, 2012). One example is the 
concept of intimacy in the SIPP-118, which was one of the facets with the lowest alpha levels 
in the study. The concept of intimacy might be perceived, characterized and understood 
differently among SUD patients than among other clinical and non-clinical populations. For 
SUD patients, intimacy might include negative references, such as the experience of shame 
related to being a substance user (Hughes, 2007; Rounsaville, Gawin, & Kleber, 1985), and 
ambivalence towards and fear of intimacy (Thorberg & Lyvers, 2006). These aspects might 
not be adequately captured by the SIPP-118 facet “capacity for intimacy”, making the facet 
less suitable for the SUD patient sample. Apart from some facets showing low alpha levels, 
the SIPP-118 seems to have adequate reliability when administered to SUD patients. 
Another relevant question concerns whether the findings in the current study are 
generalizable, and whether they can be used to make interferences about other samples of 
SUD patients. This concerns the external validity of the study. Because of time and resource 
considerations, our sample is relatively small (N=155), meaning that our sample might not be 
a representative selection from the population of SUD patients. The study sample is highly 
selected, consisting of patients who have requested SUD treatment, who are in the stage of 
detoxification and who are able to fill out an extensive questionnaire. The European 
Monitoring Centre for Drugs and Drug Addiction (2009, p. 20) suggests that “…drug users 
entering treatment can be considered as indirect indicators of the profiles and trends in the 
wider population of problem drug users”. To increase the generalizability of the finding that 
SUD patients have severe personality problems, our findings should be replicated using larger 
samples of SUD patients. 
The exact number and description of participants who did not want to participate in the study 
is not known. This can be considered a limitation of the study, as these patients might differ 
on important characteristics from the study sample. The data collection procedure and nature 
of the study have possibly excluded the patients with the poorest functioning; lowest ability to 
read or concentrate, fewest years of education, lowest level of impulse control or delay of 
gratification. This means that the average levels of personality problems in the sample might 
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be positively skewed compared to the population of SUD patients, thus showing a more 
positive picture of this patient population than what is the actual case. The fact that patients 
with the lowest levels of functioning might not be included in the study sample represents a 
limitation of the study, but if true, it accentuates our finding that SUD patients have severe 
personality problems. 
A more general limitation concerns the fact that the study is based on a cross-sectional design, 
which limits our ability to make causal interferences based on the data. Still, our main results 
concerning the severity of personality problems among SUD patients, and the fact that 
substance use characteristics seem to be unfit for screening for personality problems, stands 
with this cross-sectional design. 
4.4 Assessment of personality problems in SUD-
patients while in detoxification 
Our study proposes that there is a need for separately assessing personality problems in SUD 
patients. Questionnaire administration context can affect response accuracy (Del Boca & Noll, 
2000), thus important questions concern when and where assessment of personality problems 
should be conducted. 
The participants in our study were inpatients at detoxification units. As described in the data 
collection procedure, a detoxification stay is most likely characterized by withdrawal states 
and abstinence pains. Symptoms of withdrawal vary between substances of use, and can be as 
serious as delirium tremens (Mayo-Smith et al., 2004) and perceptual and neuropsychological 
disturbances (Tyrer, Murphy, & Riley, 1990). Typical symptoms of withdrawal are dysphoria, 
insomnia, anxiety and irritability. Del Boca & Noll’s (2000) study on the validity of self-
report assessment in SUD patients found that factors such as stage of recovery, sobriety and 
withdrawal states can influence trustworthiness of the collected data. We did not assess 
duration of abstinence before participation, thus possible residual substance effects and 
symptoms of withdrawal might challenge the validity of the questionnaire. None of the 
participants were under the (obvious) influence of their primary substance of use, but there is 
a possibility that some patients still were under the influence of psychoactive medicines 
during participation. 
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There are a number of concerns regarding personality problem assessment in SUD patients 
during the detoxification stage. In the context of detoxification with emotional uncertainty 
and withdrawal states, patients might overestimate the severity of their personality problems 
(Del Boca & Noll, 2000), or may, on the contrary, underestimate their severity. Based on the 
presented concerns, and their findings that measures of psychopathology can be unstable at 
time of treatment entry, Marlowe et al. (1997) suggest that measures of psychopathology in 
SUD patients should be conducted after more than 10 days post-intake. This corresponds to 
the general assumption that personality pathology should be assessed in a stable phase after a 
time of abstinence, and also to the DSM-5 PD diagnostic guidelines. These guidelines state 
that a diagnosis of PD should not be based “…solely on behaviors that are consequences of 
substance intoxication or withdrawal or that are associated with activities in the service of 
sustaining substance use” (American Psychiatric Association, 2013, p. 649). There are 
apparent reasons as to why assessment of personality pathology might be more informative 
and valid when done at later stages in treatment. This concerns the possibility of longer 
duration abstinence and more distance to substance use, as well as factors concerning 
stability, security and order, which may all impact response accuracy (Del Boca & Noll, 
2000). Contrary to this, a study of Norwegian SUD patients’ levels of personality pathology 
found that use of the self-report instrument MCMI gave valid clinical information when 
administered within the first two weeks of treatment initiation (Ravndal, Vaglum, & 
Lauritzen, 2005). 
We found that the overall reliability of SIPP-118 at the facet level was good when the 
questionnaire was administered to SUD patients in detoxification. The alpha scores were 
comparable to those found when administered to PD patients in Norway and the Netherlands 
(Arnevik et al., 2009; Verheul et al., 2008) and the normal population in the Netherlands 
(Verheul et al., 2008). Contrary to the context of detoxification for the SUD sample, 
personality problems in the PD patients were assessed in a more stable phase; they were 
inpatients receiving long-term day treatment in specialized PD treatment units (Arnevik et al., 
2009). Despite a different context for participation, the instrument seems to reliably assess 
personality functioning in SUD patients, showing that they have personality problems 
comparative to the PD population. Furthermore, our finding is supported by literature on 
personality functioning in SUD patients (Kandel et al., 1986; Skodol et al., 1999; Verheul, 
2001). Thus, it seems reasonable to conclude that we can assess personality problems in SUD 
patients using the SIPP-118 during the detoxification stage. 
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There are several benefits to assessing personality functioning as early as during 
detoxification. One is the possibility of addressing personality problems when establishing a 
working alliance and thus preventing premature drop-out (Brorson, Arnevik, Rand-
Hendriksen, & Duckert, 2013; Ravndal et al., 2005; Verheul, 2001).  Personality problem 
profiles might also inform the clinician of what further treatment will work best for whom, 
and thus have treatment-matching implications (Verheul, 2001). 
4.5 Clinical implications 
The findings from this study might have clinical implications for delivery and treatment 
within the SUD treatment field. Several studies have shown the effectiveness of SUD 
treatment (Gossop, 2001). Completion of treatment is associated with better mental and 
physical health, reduced substance use, increased abstinence during and after treatment, and 
reduced public costs (Brorson et al., 2013; Leshner, 1999; Morisano et al., 2014). As 
completion of treatment seems to be a crucial factor for treatment effect, high rates of drop-
out from SUD treatment is a major problem (Brorson et al., 2013). High rates of relapse 
during and after treatment also challenge the effect of SUD treatment (Bornovalova & 
Daughters, 2007). Of special concern are patients with co-occurring SUD and mental 
disorders, such as PDs. These seem to be overrepresented in challenging patient groups, 
including those who are considered “treatment failures” (Kofoed, Kania, Walsh, & Atkinson, 
1986). In this regard, it is important that SUD treatment is developed to meet the full range of 
problems SUD patients might encounter, including severe personality problems. 
The study results indicate that there is a need for greater integration of knowledge from the 
PD treatment field within SUD treatment. Clinical choices, one example being choices 
regarding treatment settings, may be more informed if aspects such as a patient’s personality 
problems are taken into consideration. Compared to SUD patients, there are stricter practice 
guidelines concerning treatment formats for patients with BPD and patients with ASPD. 
According to the NICE Guidelines for BPD (National Institute for Health and Clinical 
Excellence, 2009b, p. 24), patients should be referred for inpatient treatment only “…if there 
is a significant risk to self or others that cannot be managed within other services”. Thus, 
guidelines call for a restriction on the use of inpatient treatment for patients with a diagnosis 
of ASPD and/or BPD. The extensive use of inpatient treatment within the SUD treatment 
field might be challenged since ASPD and BPD are the PDs most frequently occurring within 
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the SUD population (Grana et al., 2009), and that SUD patients might have personality 
problems as severe as those found among PD patients. Thus, the use and effect of inpatient 
treatment in the SUD field should be the subject for further evaluation. 
The present study implies that assessing personality problems early in treatment, thus making 
possible a more integrated approach to SUD treatment, with focus on both substance related 
problems and personality problems is the best way forward. Integrated treatment is defined as 
treatments that combine, incorporate and modify aspects from one type of treatment with 
aspects from another type of treatment, so that the co-occurring disorders receive treatment 
simultaneously from the same treatment provider (American Psychiatric Association, 2006; 
Morisano et al., 2014). Integrated treatment programs seem to be cost-effective and have high 
rates of positive treatment outcome for SUD patients with co-occurring disorders (American 
Psychiatric Association, 2006; Helsedirektoratet, 2012a; Morisano et al., 2014). Kelly, Daley, 
and Douaihy (2012, p. 20) propose that “although reducing drug use is imperative for overall 
improvement during treatment, non-substance related pathology must not be neglected early 
in treatment”. Studies show that SUDs and personality pathology follow independent courses. 
Remission in SUD is not significantly associated with remission of personality dysfunction 
(Verheul, 2001), and targeting only the co-occurring pathology does not sufficiently reduce 
more specific SUD related problems (American Psychiatric Association, 2006; van den 
Bosch, Verheul, Schippers, & van den Brink, 2002). Furthermore, it is suggested that patients 
with co-occurring SUD and PD are less likely to respond favorably to traditional SUD 
treatment interventions (Ball, 1998). To prevent drop-out, maximize treatment effect and help 
SUD patients with low levels of functioning, targeting personality problems in addition to 
substance related problems in SUD treatment might be necessary. In the Norwegian national 
guidelines for treatment of patients with co-occurring SUDs and mental disorders, integrated 
treatment approaches are recommended (Helsedirektoratet, 2012a), but no recommendation 
for assessment of personality problems are referred. 
The current study indicates that the SIPP-118 might be used reliably for assessing personality 
problems in SUD patients. The instrument may also be used for clinical purposes at other 
stages in SUD treatment. One of these is assessing change in personality problem severity and 
profile during and after treatment (Verheul et al., 2008). Another clinical purpose the SIPP-
118 may serve is indicating what aspects of personality problem that could be targeted in 
treatment, by assessing levels of severity and specific areas of dysfunctioning. Examples are 
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regulation of aggressive impulses or cooperation abilities. Identifying aspects such as these, 
which are capacities believed to be modifiable due to treatment (Verheul et al., 2008), might 
give hope for improvement and higher levels of functioning. It is believed that a thorough 
understanding of the needs and problem areas of the individual patient might help staff and 
therapists work more effectively with SUD patients with personality problems (Maslin et al., 
2001), where the SIPP-118 might be an effective tool. As well as assessing levels of 
personality problems, the SIPP-118 might also be used to assess an individual’s strengths and 
resources, which corresponds to recommended focus on assessing and supporting a patient’s 
resources and strengths during and after treatment (Helsedirektoratet, 2012a). 
This study shows that substance use debut before or at age 16 is associated with more severe 
personality problems than substance use debut at later ages. This finding might indicate 
different treatment needs between early debut substance users and older debut substance 
users. Thus, treatment providers should be aware of the impact of early substance use debut 
on personality functioning and treatment needs among SUD patients. The effect of early 
substance use debut on personality functioning should be investigated further, to more 
efficiently be able to provide treatment suited to meet these patients’ needs. 
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Conclusions 
The main aim of the study was to investigate personality problems, assessed by the SIPP-118, 
among SUD patients. The results showed that SUD patients had high levels of personality 
problems. We found that personality problems among SUD patients were as severe as 
personality problems among PD patient treatment groups, and significantly less severe than 
those found in the normal population. Furthermore, we found an association between poly-
substance use, young age of substance use debut and primary preferred substance not being 
alcohol, and personality problem severity. However, none of these substance use 
characteristics were significant predictors of personality problem severity. The study therefore 
proposes a need for assessing personality problems independently in SUD patients. 
Adequate psychometric properties of the SIPP-118 when used with the study sample were a 
premise for answering our research questions. We found good reliability, as indicated by 
adequate alpha levels of the majority of the SIPP-118 facets, and adequate external validity, 
as indicated by agreement with previous research. Thus, the SIPP-118 seems to be suited for 
assessing personality problems in SUD patients while in detoxification. This is an important 
contribution to the discussion regarding time and context of personality assessment in the 
SUD field. The current study is the first to investigate personality problems assessed with the 
SIPP-118 among SUD patients. This means that the findings should be replicated using larger 
sample sizes. In addition to this, further investigation of personality problems in SUD 
patients, investigating the stability and change of these with regards to substance use effects, 
withdrawal states and effects due to treatment would be interesting supplements to the 
existing literature. 
The study supports the use of knowledge from the PD treatment field within SUD treatment, 
for example concerning recommended treatment setting. The results also infer a more 
integrated approach to SUD treatment. This is in accordance with the Norwegian national 
clinical guidelines for treatment of patients with SUDs and mental disorders, as well as 
several studies showing the effect of integrated treatment programs for SUD patients. The 
clinical use of the SIPP-118, as a tool for assessing personality problem severity, for assessing 
areas of dysfunctioning and resources as well as change in personality problem profile due to 
treatment, is promising.  
41 
 
References 
Allport, G. W. (1937). Personality: a Psychological Interpretation. Oxford, England. 
American Psychiatric Association. (2006). Practice guideline for the treatment of patients 
with substance use disorders. Retrieved from Washington, DC: 
http://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/subst
anceuse.pdf 
American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental 
Disorders (5th ed.). Washington, DC: Author. 
Andrea, H., Verheul, R., Berghout, C., Dolan, C., van der Kroft, P., Bateman, A. W., . . . 
Busschbach, J. J. V. (2007). Measuring the core components of maladaptive 
personality: Severity Indices of Personality Problems (SIPP-118) (No. Report 005). 
Medical Psychology and Psychotherapy: Reports.  Retrieved from 
http://hdl.handle.net/1765/10066 
Arefjord, N. (2011). Personlighetsforstyrrelser og ruslidelser. In K. Lossius (Ed.), Håndbok i 
Rusbehandling, Til pasienter med moderat til alvorlig rusavhengighet (pp. 81-102). 
Oslo: Gyldendal Akademisk. 
Arnevik, E., Wilberg, T., Monsen, J. T., Andrea, H., & Karterud, S. (2009). A cross-national 
validity study of the Severity Indices of Personality Problems (SIPP-118). Personality 
and Mental Health, 3(1), 41-55. doi:10.1002/Pmh.60 
Ball, S. A. (1998). Manualized treatment for substance abusers with personality disorders: 
Dual Focus Schema Therapy. Addictive Behaviors, 23(6), 883-891. 
doi:10.1016/S0306-4603(98)00067-7 
Bastiaansen, L., De Fruyt, F., Rossi, G., Schotte, C., & Hofmans, J. (2013). Personality 
disorder dysfunction versus traits: Structural and conceptual issues. Personality 
Disorders: Theory, Research, and Treatment, .4(4), pp. doi:10.1037/per0000018 
23834515 
Beletsky, L., Davis, C. S., Anderson, E., & Burris, S. (2008). The law (and politics) of safe 
injection facilities in the United States. American Journal of Public Health, 98(2), 
231-237. doi:10.2105/Ajph.2006.103747 
Bordens, K. S., & Abbott, B. B. (2008). Research design and methods: A process approach 
(7th ed.). New York: Mc Graw-Hill Education. 
Bornovalova, M. A., & Daughters, S. B. (2007). How does dialectical behavior therapy 
facilitate treatment retention among individuals with comorbid borderline personality 
 42 
 
disorder and substance use disorders? Clinical Psychology Review, 27(8), 923-943. 
doi:10.1016/j.cpr.2007.01.013 
Brorson, H. H., Arnevik, E. A., Rand-Hendriksen, K., & Duckert, F. (2013). Drop-out from 
addiction treatment: A systematic review of risk factors. Clinical Psychology Review, 
33(8), 1010-1024. doi:10.1016/j.cpr.2013.07.007 
Campbell, A. N. C., Nunes, E. V., McClure, E. A., Hu, M. C., Turrigiano, E., Goldman, B., & 
Stabile, P. Q. (2013). Characteristics of an outpatient treatment sample by primary 
substance of abuse. Journal of Addiction Medicine, 7(5), 363-371. 
doi:10.1097/ADM.0b013e31829e3971 
Carver, C. S., & Miller, C. J. (2006). Relations of serotonin function to personality: Current 
views and a key methodological issue. Psychiatry Research, 144(1), 1-15. 
doi:10.1016/j.psychres.2006.03.013 
Cohen, J. (1992). Statistical power analysis. Current Directions in Psychological Science, 
1(3), 98-101.  Retrieved from http://www.jstor.org/stable/20182143 
Colpaert, K., De Maeyer, J., Broekaert, E., & Vanderplasschen, W. (2013). Impact of 
addiction severity and psychiatric comorbidity on the quality of life of alcohol-, drug- 
and dual-dependent persons in residential treatment. European Addiction Research, 
19(4), 173-183. doi:10.1159/000343098 
Conway, K. P., Kane, R. J., Ball, S. A., Poling, J. C., & Rounsaville, B. J. (2003). Personality, 
substance of choice, and poly-substance involvement among substance dependent 
patients. Drug and Alcohol Dependence, 71, 65-75. doi:10.1016/S0376-
8716(03)00068-1 
Darke, S. (1998). Self-report among injecting drug users: A review. Drug and Alcohol 
Dependence, 51(3), 253-263. doi:10.1016/S0376-8716(98)00028-3 
Del Boca, F. K., & Noll, J. A. (2000). Truth or consequences: The validity of self-report data 
in health services research on addictions. Addiction, 95, S347-S360. 
doi:10.1080/09652140020004278 
DeVellis, R. (2012). Scale development, theory and applications (3rd ed.): Sage Publications. 
Di Poggio, A. B., Fornai, F., Paparelli, A., Pacini, M., Perugi, G., & Maremmani, I. (2006). 
Comparison between heroin and heroin-cocaine polyabusers - A psychopathological 
study. Cellular and Molecular Mechanisms of Drugs of Abuse and Neurotoxicity: 
Cocaine, Ghb, and Substituted Amphetamines, 1074, 438-445. 
doi:10.1196/annals.1369.044 
43 
 
Domier, C. P., Simon, S. L., Rawson, R. A., Huber, A., & Ling, W. (2000). A comparison of 
injecting and noninjecting methamphetamine users. Journal of Psychoactive Drugs, 
32(2), 229-232. doi:10.1080/02791072.2000.10400233 
European Monitoring Centre for Drugs and Drug Addiction. (2009). Polydrug use: Patterns 
and responses. Retrieved from Lisbon: 
http://www.emcdda.europa.eu/publications/selected-issues/polydrug-use 
European Monitoring Centre for Drugs and Drug Addiction. (2014). The levels of use of 
opioids, amphetamines and cocaine and associated levels of harm: Summary of 
scientific evidence. Retrieved from Lisbon: 
http://www.emcdda.europa.eu/publications/literature-review/2014/levels-of-harm 
Feenstra, D. J., Hutsebaut, J., Verheul, R., & Busschbach, J. J. V. (2011). Severity Indices of 
Personality Problems (SIPP-118) in adolescents: Reliability and validity. 
Psychological Assessment, 23(3), 646-655. doi:10.1037/a0022995 
Fernandez-Serrano, M. J., Lozano, O., Perez-Garcia, M., & Verdejo-Garcia, A. (2010). 
Impact of severity of drug use on discrete emotions recognition in polysubstance 
abusers. Drug and Alcohol Dependence, 109(1-3), 57-64. 
doi:10.1016/j.drugalcdep.2009.12.007 
Field, A. (2009). Discovering Statistics using IBM SPSS Statistics (3rd ed.). London: Sage 
publications. 
Flores, P. J. (2001). Addiction as an attachment disorder: Implications for group therapy. 
International Journal of Group Psychotherapy, 51(1), 63-81. 
doi:10.1521/ijgp.51.1.63.49730 
Flynn, P. M., & Brown, B. S. (2008). Co-occurring disorders in substance abuse treatment: 
Issues and prospects. Journal of Substance Abuse Treatment, 34(1), 36-47. 
doi:10.1016/j.jsat.2006.11.013 
Folkehelseinstituttet. (2014). Folkehelserapporten 2014: Helsetilstanden i Norge. Retrieved 
from Oslo, Norway: http://www.fhi.no/dokumenter/4313e1cf39.pdf 
Fridell, M., & Hesse, M. (2006). Psychiatric severity and mortality in substance abusers - A 
15-year follow-up of drug users. Addictive Behaviors, 31(4), 559-565. 
doi:10.1016/j.addbeh.2005.05.036 
Gonzales, R., Ang, A., Glik, D. C., Rawson, R. A., Lee, S., & Iguchi, M. Y. (2011). Quality 
of life among treatment seeking methamphetamine-dependent individuals. American 
Journal on Addictions, 20(4), 366-372. doi:10.1111/j.1521-0391.2011.00142.x 
Gossop, M. (2001). Drug addiction and its treatment. Oxford: Univesity Press. 
 44 
 
Gossop, M., Griffiths, P., Powis, B., & Strang, J. (1992). Severity of dependence and route of 
administration of heroin, cocaine and amphetamines. British Journal of Addiction, 
87(11), 1527-1536. doi:10.1111/j.1360-0443.1992.tb02660.x 
Grana, J. L., Munoz, J. J., & Navas, E. (2009). Normal and pathological personality 
characteristics in subtypes of drug addicts undergoing treatment. Personality and 
Individual Differences, 46(4), 418-423. doi:10.1016/j.paid.2008.11.011 
Grant, B. F., Stinson, F. S., Dawson, D. A., Chou, S. P., Ruan, W. J., & Pickering, R. P. 
(2004). Co-occurrence of 12-month alcohol and drug use disorders and personality 
disorders in the United States: Results From the National Epidemiologic Survey on 
Alcohol and Related Conditions. Archives of General Psychiatry, .61(4), pp. 
doi:10.1001/archpsyc.61.4.361 15066894 
Gruber, E., DiClemente, R. J., Anderson, M. M., & Lodico, M. (1996). Early drinking onset 
and its association with alcohol use and problem behavior in late adolescence. 
Preventive Medicine, 25(3), 293-300. doi:10.1006/pmed.1996.0059 
Hatlebakk, I. M. (2014). Rusbehandling - mye i privat regi. Samfunnsspeilet, 2, 16-19.  
Retrieved from https://www.ssb.no/helse/artikler-og-publikasjoner/rusbehandling-
mye-i-privat-regi 
Helsedirektoratet. (2012a). Nasjonal faglig retningslinje for utredning, behandling og 
oppfølging av personer med samtidig rus - og psykisk lidelse - ROP lidelser. Oslo 
Retrieved from 
https://helsedirektoratet.no/Lists/Publikasjoner/Attachments/188/Nasjonal-faglig-
retningslinje-personer-med-rop-lidelser-IS-1948.pdf. 
Helsedirektoratet. (2012b). Prioriteringsveileder Tverrfaglig Spesialisert Rusbehandling 
(TSB). Retrieved from https://helsedirektoratet.no/retningslinjer/prioriteringsveileder-
for-tverrfaglig-spesialisert-rusbehandling-tsb 
Holi, M. M., Sammallahti, P. R., & Aalberg, V. A. (1998). A Finnish validation study of the 
SCL-90. Acta Psychiatrica Scandinavica, 97(1), 42-46. doi:10.1111/j.1600-
0447.1998.tb09961.x 
Hopfer, C. J., Mikulich, S. K., & Crowley, T. J. (2000). Heroin use among adolescents in 
treatment for substance use disorders. Journal of the American Academy of Child and 
Adolescent Psychiatry, 39(10), 1316-1323. doi:10.1097/00004583-200010000-00021 
Hughes, K. (2007). Migrating identities: the relational constitution of drug use and addiction. 
Sociology of Health & Illness, 29(5), 673-691. doi:10.1111/j.1467-9566.2007.01018.x 
Interactive Statistics. (2015). http://statpages.org/anova1sm.html.    
45 
 
International Narcotics Control Board. (2013). Report 2013. Retrieved from United Nations 
Publication: 
https://www.incb.org/documents/Publications/AnnualReports/AR2013/English/AR_2
013_E.pdf 
Jahng, S., Trull, T. J., Wood, P. K., Tragesser, S. L., Tomko, R., Grant, J. D., . . . Sher, K. J. 
(2011). Distinguishing general and specific personality disorder features and 
implications for substance dependence comorbidity. Journal of Abnormal Psychology, 
120(3), 656-669. doi:10.1037/A0023539 
Kandel, D. B., Davies, M., Karus, D., & Yamaguchi, K. (1986). The consequences in young 
adulthood of adolescent drug involvement - an overview. Archives of General 
Psychiatry, 43(8), 746-754. doi:10.1001/archpsyc.1986.01800080032005 
Karterud, S., Wilberg, T., & Urnes, Ø. (2010). Personlighetspsykiatri. Oslo: Gyldendal 
akademisk. 
Kelly, T. M., Daley, D. C., & Douaihy, A. B. (2012). Treatment of substance abusing patients 
with comorbid psychiatric disorders. Addictive Behaviours, 37(1), 11-24. 
doi:10.1016/j.addbeh.2011.09.010 
Kofoed, L., Kania, J., Walsh, T., & Atkinson, R. M. (1986). Outpatient treatment of patients 
with substance-abuse and coexisting psychiatric disorders. American Journal of 
Psychiatry, 143(7), 867-872.  Retrieved from <Go to ISI>://WOS:A1986C994200009 
Kokkevi, A., & Hartgers, C. (1995). EuropASI: European adaptation of a multidimensional 
assessment instrument for drug and alcohol dependence. European Addiction 
Research, 1, 208-210.  Retrieved from https://www.karger.com/Article/Pdf/259089 
Kokkevi, A., Hartgers, C., Blanken, P., Hendriks, V., Pozzi, G., Tempesta, E., . . . 
Uchtenhagen, A. (1994). European Addiction Severity Index, a guide to training and 
administering EuropASI interviews. Retrieved from Zürich: 
http://www.dldocs.stir.ac.uk/documents/europASI-manual.pdf 
Kranzler, H. R., & Li, T. K. (2008). What is addiction? Alcohol Research & Health, 31(2), 
93-95.  Retrieved from 
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3860451/pdf/arh-31-2-93.pdf 
Landheim, A. S., Bakken, K., & Vaglum, P. (2003). Gender differences in the prevalence of 
symptom disorders and personality disorders among poly-substance abusers and pure 
alcoholics. Substance abusers treated in two counties in Norway. European Addiction 
Research, 9(1), 8-17. doi:10.1159/000067732 
 46 
 
Langås, A. M., Malt, U. F., & Opjordsmoen, S. (2012). In-depth study of personality 
disorders in first-admission patients with substance use disorders. Bmc Psychiatry, 12. 
doi:10.1186/1471-244x-12-180 
Latimer, W. W., Newcomb, M., Winters, K. C., & Stinchfield, R. D. (2000). Adolescent 
substance abuse treatment outcome: The role of substance abuse problem severity, 
psychosocial, and treatment factors. Journal of Consulting and Clinical Psychology, 
68(4), 684-696. doi:10.1037//0022-006X.68.4.684 
Leshner, A. I. (1999). Science-based views of drug addiction and its treatment. Jama-Journal 
of the American Medical Association, 282(14), 1314-1316. 
doi:10.1001/jama.282.14.1314 
Livesley, W. J., & Jang, K. L. (2000). Toward an empirically based classification of 
personality disorder. Journal of Personality Disorders, 14(2), pp. 
doi:10.1521/pedi.2000.14.2.137 10897464 
Livesley, W. J., & Jang, K. L. (2005). Differentiating normal, abnormal, and disordered 
personality. European Journal of Personality, .19(4), pp. doi:10.1002/per.559 
López-Goñi, J. J., Fernández-Montalvo, J., & Arteaga, A. (2012). Predictive validity of the 
EuropASI: Clinical diagnosis or composite scoring? Journal of Substance Abuse 
Treatment, 42, 392-399. doi:10.1016/j.jsat.2011.09.011 
Lynam, D. R. (2012). Assessment of maladaptive variants of five-factor model traits. Journal 
of Personality, 80(6), 1593-1614. doi:10.1111/j.1467-6494.2012.00775.x 
Magid, V., & Moreland, A. D. (2014). The role of substance use initiation in adolescent 
development of subsequent substance-related problems. Journal of Child & 
Adolescent Substance Abuse, 23(2), 78-86. doi:10.1080/1067828x.2012.748595 
Marlowe, D. B., Husband, S. D., Bonieskie, L. M., Kirby, K. C., & Platt, J. J. (1997). 
Structured interview versus self-report test vantages for the assessment of personality 
pathology in cocaine dependence. Journal of Personality Disorders, 11(2), 177-190.  
Retrieved from <Go to ISI>://WOS:A1997XF77300007 
Maslin, J., Graham, H. L., Cawley, M., Copello, A., Birchwood, M., Georgiou, G., . . . 
Orford, J. (2001). Combined severe mental health and substance use problems: What 
are the training and support needs of staff working with this client group? Journal of 
Mental Health, 10(2), 131-140. doi:10.1080/09638230020023697 
Mayo-Smith, M. F., Beecher, L. H., Fischer, T. L., Gorelick, D. A., Guillaume, J. L., Hill, A., 
. . . Melbourne, J. (2004). Management of alcohol withdrawal delirium: An evidence-
47 
 
based practice guideline (vol 164, pg 1405, 2004). Archives of Internal Medicine, 
164(18), 2068-2068. doi:10.1001/archinte.164.13.1405 
Miele, G. M., Carpenter, K. M., Cockerham, M. S., Trautman, K. D., Blaine, J., & Hasin, D. 
S. (2000). Substance Dependence Severity Scale (SDSS): reliability and validity of a 
clinician-administered interview for DSM-IV substance use disorders. Drug and 
Alcohol Dependence, 59(1), 63-75. doi:10.1016/S0376-8716(99)00111-8 
Morisano, D., Babor, T. F., & Robaina, K. A. (2014). Co-occurrence of substance use 
disorders with other psychiatric disorders: Implications for treatment services. Nordic 
Studies on Alcohol and Drugs, 31(1), 5-25. doi:10.2478/nsad-2014-0002 
National Institute for Health and Clinical Excellence. (2009a). Antisocial personality 
disorder: Treatment, management and prevention. Manchester: NICE Guideline (cg 
77) Retrieved from https://www.nice.org.uk/guidance/cg77. 
National Institute for Health and Clinical Excellence. (2009b). Borderline personality 
disorder: Treatment and management. Manchester: NICE Guideline (cg78) Retrieved 
from https://www.nice.org.uk/guidance/cg78. 
Petrar, S., Kerr, T., Tyndall, M. W., Zhang, R., Montaner, J. S. G., & Wood, E. (2007). 
Injection drug users' perceptions regarding use of a medically supervised safer 
injecting facility. Addictive Behaviors, 32(5), 1088-1093. 
doi:10.1016/j.addbeh.2006.07.013 
Psychometrica. (2015). http://www.psychometrica.de/effect_size.html#cohenb.    
Ravndal, E., Vaglum, P., & Lauritzen, G. (2005). Completion of long-term inpatient treatment 
of drug abusers: A prospective study from 13 different units. European Addiction 
Research, 11(4), 180-185. doi:10.1159/000086399 
Roberts, B. W. (2009). Back to the future: Personality and assessment and personality 
development. Journal of Research in Personality, 43(2), 137-145. 
doi:10.1016/j.jrp.2008.12.015 
Rounsaville, B. J., Gawin, F., & Kleber, H. (1985). Interpersonal psychotherapy adapted for 
ambulatory cocaine abusers. American Journal of Drug and Alcohol Abuse, 11(3-4), 
171-191. doi:10.3109/00952998509016860 
Ryder, A. G., Costa, P. T., & Bagby, R. M. (2007). Evaluation of the SCID-II personality 
disorder traits for DSM-IV: Coherence, discrimination, relations with general 
personality traits, and functional impairment. Journal of Personality Disorders, 21(6), 
626-637. doi:10.1521/pedi.2007.21.6.626 
 48 
 
Saint-Lebes, J., Rodgers, R., Birmes, P., & Schmitt, L. (2012). Personality differences 
between drug injectors and non-injectors among substance-dependent patients in 
substitution treatment. American Journal of Drug and Alcohol Abuse, 38(2), 135-139. 
doi:10.3109/00952990.2011.643982 
Saulsman, L. M., & Page, A. C. (2004). The five-factor model and personality disorder 
empirical literature: A meta-analytic review. Clinical Psychology Review, 23(8), 1055-
1085. doi:10.1016/j.cpr.2002.09.001 
Schmitz, N., Hartkamp, N., Kiuse, J., Franke, G. H., Reister, G., & Tress, W. (2000). The 
Symptom Check-List-90-R (SCL-90-R): a German validation study. Quality of Life 
Research, 9(2), 185-193.  Retrieved from 
http://www.ncbi.nlm.nih.gov/pubmed/10983482 
Sher, K. J., & Trull, T. J. (2002). Substance use disorder and personality disorder. Current 
Psychiatry Reports, 4(1), 25-29.  Retrieved from 
http://www.ncbi.nlm.nih.gov/pubmed/11814392 
SIRUS. (2014a). Narkotikabruk på gateplan i syv norske byer. Retrieved from Oslo: 
http://www.sirus.no/publikasjon/rapporter/2014-2/narkotikabruk-pa-gateplan-i-7-
norske-byer/ 
SIRUS. (2014b). Rusmidler i Norge 2014. Retrieved from Oslo: 
http://www.sirus.no/publikasjon/rusmidler-i-norge/ 
Skodol, A. E., Oldham, J. M., & Gallaher, P. E. (1999). Axis II comorbidity of substance use 
disorders among patients referred for treatment of personality disorders. American 
Journal of Psychiatry, 156(5), 733-738.  Retrieved from <Go to 
ISI>://WOS:000080095400011 
Stewart, J., Dewit, H., & Eikelboom, R. (1984). Role of unconditioned and conditioned drug 
effects in the self-administration of opiates and stimulants. Psychological Review, 
91(2), 251-268. doi:10.1037/0033-295x.91.2.251 
Strang, J., Bearn, J., Farrell, M., Finch, E., Gossop, M., Griffiths, P., . . . Wolff, K. (1998). 
Route of drug use and its implications for drug effect, risk of dependence and health 
consequences. Drug and Alcohol Review, 17(2), 197-211. 
doi:10.1080/09595239800187001 
Taplin, C., Saddichha, S., Li, K., & Krausz, M. R. (2014). Family history of alcohol and drug 
abuse, childhood trauma, and age of first drug injection. Substance Use & Misuse, 
49(10), 1311-1316. doi:10.3109/10826084.2014.901383 
49 
 
Thorberg, F. A., & Lyvers, M. (2006). Attachment, fear of intimacy and differentiation of self 
among clients in substance disorder treatment facilities. Addictive Behaviors, 31(4), 
732-737. doi:10.1016/j.addbeh.2005.05.050 
Trenz, R. C., Scherer, M., Harrell, P., Zur, J., Sinha, A., & Latimer, W. (2012). Early onset of 
drug and polysubstance use as predictors of injection drug use among adult drug users. 
Addictive Behaviors, 37(4), 367-372. doi:10.1016/j.addbeh.2011.11.011 
Trull, T. J., Sher, K. J., Minks-Brown, C., Durbin, J., & Burr, R. (2000). Borderline 
personality disorder and substance use disorders: A review and integration. Clinical 
Psychology Review, 20(2), 235-253. doi:10.1016/S0272-7358(99)00028-8 
Tyrer, P., Murphy, S., & Riley, P. (1990). The Benzodiazepine Withdrawal Symptom 
Questionnaire. Journal of Affective Disorders, 19(1), 53-61. doi:10.1016/0165-
0327(90)90009-W 
United Nations Office on Drugs and Crime. (2012). World Drug Report. Retrieved from 
Vienna: https://www.unodc.org/documents/data-and-
analysis/WDR2012/WDR_2012_web_small.pdf 
van den Bosch, L. M., & Verheul, R. (2007). Patients with addiction and personality disorder: 
Treatment outcomes and clinical implications. Current Opinion in Psychiatry, 20(1), 
pp. doi:10.1097/YCO.0b013e328011740c 17143086 
van den Bosch, L. M., Verheul, R., Schippers, G. M., & van den Brink, W. (2002). Dialectical 
behavior therapy of borderline patients with and without substance use problems. 
Implementation and long-term effects. Addictive Behaviours, 27(6), 911-923.  
Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/12369475 
van Kampen, D. (2002). The DAPP-BQ in The Netherlands: Factor structure and relationship 
with basic personality dimensions. Journal of Personality Disorders, 16(3), 235-254.  
Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/12136680 
Verheul, R. (2001). Co-morbidity of personality disorders in individuals with substance use 
disorders. European Psychiatry, 16(5), pp. doi:10.1016/S0924-9338%2801%2900578-
8 11514129 
Verheul, R., Andrea, H., Berghout, C. C., Dolan, C., Busschbach, J. J. V., van der Kroft, P. J. 
A., . . . Fonagy, P. (2008). Severity Indices of Personality Problems (SIPP-118): 
Development, factor structure, reliability, and validity. Psychological Assessment, 
20(1), 23-34. doi:10.1037/1040-3590.20.1.23 
 50 
 
Verheul, R., & van den Brink, W. (2000). The role of personality pathology in the aetiology 
and treatment of substance use disorders. Current Opinion in Psychiatry, 13(2), 163-
169. doi:10.1097/00001504-200003000-00005 
Verheul, R., & van den Brink, W. (2005). Causal pathways between substance use disorders 
and personality pathology. Australian Psychologist, 40(2), 127-136. 
doi:10.1080/00050060500094613 
Verheul, R., van den Brink, W., & Hartgers, C. (1995). Prevalence of personality disorders 
among alcoholics and drug addicts: An overview. European Addiction Research, 1, 
166-177. doi:10.1159/000259080 
West, R., & Brown, J. (2013). Theory of addiction (2nd ed.). Oxford: Wiley Blackwell. 
WHO. (1992). The ICD-10 classification of mental and behavioural disorders: Clinical 
descriptions and diagnostic guidelines. Geneva: World Health Organization. 
Wu, L. T., Pilowsky, D. J., Wechsberg, W. M., & Schlenger, W. E. (2004). Injection drug use 
among stimulant users in a national sample. American Journal of Drug and Alcohol 
Abuse, 30(1), 61-83. doi:10.1081/Ada-120029866 
 
51 
 
Appendix  
Appendix: The study questionnaire.  
Oslo Universitetssykehus HF 
Aker sykehus 
Postboks 4959 Nydalen 
0424 Oslo 
Sentralbord: 02770 
Klinikk psykisk helse og avhengighet 
Rus- og avhengighetsbehandling, avdeling 
TSB Nasjonal kompetansetjeneste, seksjon 
 
Forespørsel om deltakelse i forskningsprosjekt 
«Sammenhengen mellom alvorlighetsgrad på ruslidelse og 
personlighetsproblemer – implikasjoner for behandling» 
 
Bakgrunn og hensikt 
Personlighet omfatter mer eller mindre stabile mønstre av hvordan vi tenker, føler og 
forholder oss til andre mennesker. Personligheten kan ha betydning for livskvaliteten på 
forskjellige områder i livet, og kan også ha sammenheng med forskjellige former for 
helseproblemer. Pasienter med ruslidelser har ofte personlighetsproblemer. Disse problemene 
kan gi vansker med å fungere i dagliglivet og redusert livskvalitet, og kan vanskeliggjøre 
sosial/relasjonell fungering og selv-fungering. Prosjektet vil gi informasjon om hvilke 
personlighetsproblemer man ofte finner hos pasienter med ruslidelser. Prosjektet ønsker å 
belyse hvilken sammenheng det er mellom alvorlighetsgrad på ruslidelse og 
personlighetsproblemer hos et utvalg pasienter med ruslidelser. Formålet er å bedre 
behandlingen for pasienter med ruslidelser. Datainnsamlingen er del av et 
hovedoppgaveprosjekt ved Universitetet i Oslo. 
Hva innebærer prosjektet? 
Du vil få utdelt SIPP-118, et spørreskjema med 118 spørsmål, pluss 15 tilleggsspørsmål som 
vi ber deg om å fylle ut. Dette skal normalt sett ta rundt 30 minutter.  
Mulige fordeler og ulemper 
Det er ingen fordeler for deg knyttet til deltakelse i forskningsprosjektet, men mange vil 
oppleve det som meningsfullt å bidra til forskning på et viktig felt som det finnes forholdsvis 
lite forskning på. Det er heller ingen ulemper knyttet til deltakelse, bortsett fra at du må sette 
av rundt 30 minutter til å besvare spørreskjemaet. Enkelte av spørsmålet kan være personlige, 
men skal i utgangspunktet ikke virke støtende eller krenkende.  
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Hva skjer med informasjonen om deg? 
Informasjonen som registreres om deg skal kun brukes slik som beskrevet i hensikten med 
prosjektet. Alle opplysninger vil bli behandlet uten navn og fødselsnummer eller andre direkte 
gjenkjennende opplysninger. Det vil ikke være mulig å identifisere deg i verken databasen 
eller i resultatene av prosjektet. 
Frivillig deltakelse 
Det er frivillig å delta i studien. Dersom du ikke ønsker å være med i prosjektet vil det ikke få 
noen konsekvenser for din behandling.  
Dersom du har spørsmål om prosjektet kan du kontakte hovedoppgavestudent Ingebjørg 
Aspeland Lien ingebjal@student.sv.uio.no, eller Espen Ajo Arnevik esarne@ous-hf.no. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
53 
 
Spørreskjema om personlighet 
Veiledning 
På de følgende sidene finner du en rekke utsagn. Ved hvert av dem er det en ”boks” som du skal 
bruke for å markere hvor godt disse beskriver deg. Når du besvarer skal du fokusere på hvordan du 
mener du har vært de siste tre månedene. 
 
Hvis du er helt uenig, marker du dette ved å sette et kryss i den venstre boksen. Hvis du er helt 
enig, marker du dette ved å sette et kryss i den høyre boksen. Dersom du mener at sannheten ligger 
et eller annet sted i mellom, markerer du dette ved å sette et kryss i den boksen best tilsvarer det du 
mener. Les utsagnene nøye, men ikke tenk deg om for lenge. Din første innskytelse er vanligvis 
den beste. 
 
Med tanke på de siste tre mådeder, i hvilken grad er du enig i følgende utsagn? Helt Delvis Delvis Helt 
 uenig uenig enig enig 
 1 Jeg kan takle skuffelser svært godt  ......................................................................................     
 2 Av og til blir jeg så overveldet at jeg ikke kan kontrollere reaksjonene mine  .......................     
 3 Når jeg blir opprørt av noen, får jeg ofte lyst til å såre vedkommende  .................................     
 4 Jeg vet nøyaktig hvem jeg er og hva jeg er verdt  ................................................................     
 5 Når jeg føler noe, kan jeg nesten alltid sette ord på den følelsen  ........................................     
 6 Det er vanskelig for meg å se på meg selv som en verdifull person  ....................................     
 7 Jeg føler meg konstant misforstått av andre mennesker  .....................................................     
 8 Det er lett for meg å akseptere folk som de er, selv om de er annerledes enn meg  ...........     
 9 Jeg er overbevist om at livet er verdt å leve  .........................................................................     
 10 I det store og hele føler jeg at jeg har glede av det jeg gjør  .................................................     
 11 Jeg kan arbeide sammen med andre på et felles prosjekt til tross for 
  personlige motsetninger  .......................................................................................................     
 12 Jeg møter sjelden noen som jeg tør dele mine tanker og følelser med  ...............................     
 13 Jeg har mennesker i livet mitt som jeg føler spesiell nærhet til  ............................................     
 14 Jeg gjør ting selv når jeg vet at de kan bli sett på som uansvarlige av andre  ......................     
 15 Hvis jeg har blitt enig med andre om en handlingsplan, 
  holder jeg meg vanligvis til avtalen  .......................................................................................     
 16 Jeg blir irritert når ting ikke går min vei ..................................................................................     
 17 Jeg har vanligvis god nok kontroll over følelsene mine  ........................................................     
 18 Noen ganger blir jeg så sint at jeg får lyst til å slå eller sparke folk ......................................     
 19 Som oftest forstår jeg hvorfor jeg gjør det jeg gjør  ...............................................................     
 20 Av og til får jeg lyst til å skade eller straffe meg selv med vilje  ............................................     
 21 Jeg er overbevist om at andre ikke kan lære meg å kjenne slik jeg virkelig er  ....................     
 22 Det er vanskelig for meg å respektere folk som har ideer som er forskjellige fra mine  .......     
 23 Jeg ser ofte ikke noen grunn til å fortsette å leve  .................................................................     
 24 Jeg bruker mye tid på å gjøre ting som må gjøres, men som ikke gir meg noe glede  ........     
 25 Jeg foretrekker å arbeide alene så jeg ikke trenger å tilpasse meg andre  ..........................     
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 27 Det er vanskelig for meg å bli knyttet til noen annen  ...........................................................     
 28 Jeg er en som ikke alltid holder meg til reglene, særlig når det er lett å ignorere dem  .......     
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 49 Selv blant gode venner viser jeg ikke mye av meg selv  .......................................................     
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 82 Andre synes at jeg er vinglete  ..............................................................................................     
 83 Jeg blir ofte forvirret over hvordan jeg handler, 
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Vennligst kryss av for om du er Mann  eller Kvinne  
 
Vennligst oppgi din alder:  år 
 
Har du fullført ungdomsskole? (sett kryss) Ja  Nei  
 
Har du fullført videregående skole ellet tatt fagbrev? (sett kryss) Ja  Nei  
 
Har du fullført høgskole eller universitetsutdannelse? (sett kryss) Ja  Nei  
 
Hvor gammel var du første gang du brukte et rusmiddel?  år. 
 
Når fikk du diagnosen «ruslidelse» første gang?  år. 
 
Hva er ditt primære foretrukne rusmiddel? (sett kryss)  
Alkohol ……………………………………………..   
Heroin ……………………………………………….   
Metadon/subutex (andre substitusjonsmedikamenter)   
Andre opiater  ………………………………………  
Dempende medisiner (benzodiazepiner, sedativa) ..    
Kokain …………………………………………….    
Amfetaminer  ……………………………………    
Cannabis ………………………………………….    
Hallusinogener ……………………………………    
Sniffestoffer ………………………………………….   
Andre  ………………………………………………  
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Hva er ditt sekundære foretrukne rusmiddel? (sett kryss)  
Alkohol ……………………………………………..   
Heroin ……………………………………………….   
Metadon/subutex (andre substitusjonsmedikamenter)   
Andre opiater  ………………………………………  
Dempende medisiner (benzodiazepiner, sedativa) ..    
Kokain …………………………………………….    
Amfetaminer  ……………………………………    
Cannabis ………………………………………….    
Hallusinogener ……………………………………    
Sniffestoffer ………………………………………….   
Andre  ………………………………………………  
 
 
Bruker du vanligvis flere rusmidler/medikamenter per dag? (sett kryss) Ja  Nei  
 
Hva er din vanligste bruksmåte for primært foretrukne rusmiddel? (sett kryss)  
Oralt ……………………………………..    
Nasalt ……………………………………    
Røyking …………………………………    
Ikke intravenøs injeksjon (ikke i blodåre)    
Intravenøs injeksjon (i blodåre) ………..   
 
Har du noen gang tatt stoff med sprøyte? Ja  Nei  
 
Hvis ja, hvor gammel var du første gang du gjorde dette?  år. 
 
Hvor mange måneder har din lengste periode med rusfrihet vart?  måneder 
 
Hvilken/hvilke av disse typene behandling har du mottatt før denne? (sett kryss for hver av 
behandlingstypene du har mottatt)  
Poliklinisk avrusning ………………   
Avrusning i institusjon……………     
Poliklinisk vedlikeholdsbehandling     
Annen poliklinisk behandling ……..    
Institusjonsbehandling …………….    
Dagtilbud …………………………     
Psykiatrisk sykehus ……………….    
Somatisk sykehus …………………    
Annen behandling …………………   
 
 
